Home » Posts tagged 'development'
Tag Archives: development
#BRES Blencowe Resources PLC – Half-year Report
The Company is pleased to announce its Interim Results for the six-month period to 31 March 2024.
Electronic copies of the report will be available at the Company’s website www.blencoweresourcesplc.com
For further information please contact:
Blencowe Resources Sam Quinn
|
Tel: +44 (0) 1624 681 250
|
Investor Enquiries Sasha Sethi |
Tel: +44 (0) 7891 677 441
|
Tavira Securities Limited Jonathan Evans |
Tel: +44 (0)203 192 1733 jonathan.evans@tavirasecurities.com
|
Interim Management Report
This report covers the period 30 September 2023 to 31 March 2024, and subsequent events to 30 April 2024.
Work has been progressing on many fronts, on four continents, as the Orom-Cross Definitive Feasibility Study “(DFS”) gathers momentum.
In September the long-awaited Technical Assistance Grant Agreement (“TAG”) was signed with the US Government’s private sector investment arm, the Development Finance Corporation (“DFC”). This is a US$5 million grant awarded to Blencowe to assist with DFS costs and it is with pleasure I note that Blencowe is the first pre-production graphite company to receive such a grant from the US Government. Aside from the obvious advantages of having approximately 40% of our overall DFS costs being funded for free the credibility of both our Company and our Orom-Cross project are both significantly raised by having a partner of this calibre. Blencowe wishes to state once again our appreciation to DFC for this grant and all efforts will be made to deliver a first class DFS as a result.
To date US$3 million of this grant funding has been received as tranches are delivered on DFS milestones being achieved. It is our expectation that the final US$2 million will be received over the next six months for further work and ultimately completion of DFS. In addition, DFC is mandated to play a role as lead partner in a funding solution for Orom-Cross implementation ahead, and management are working closely with DFC to ensure that this will happen as substantial funding solutions remain the largest challenge for any new graphite project, so to have DFC involved adds significant weight and prestige, and a potential funding party with US$5 million skin in the game.
During this period several key milestones have been met with regards to actual DFS work. In 2H 2023 a 100-tonne bulk sample was mined and delivered to a technical facility in northern China which is a leading expert on graphite processing, and this ore was then beneficiated into 96% LOI concentrate. This in turn provides offtakers with the knowledge that commercial scale processing of Orom-Cross ore can deliver same high quality results as all lab-scale testing has shown to date, and secondly to provide a substantial quantum of 96% concentrate for Blencowe to send to various parties as samples, for testing and review. Following the success of this action, and the request of several tier one potential offtake partners, Blencowe has more recently mined a further 600-tonne bulk sample and sent it to the same facility, for the same reasons. This latest sample will also be beneficiated beyond 96% concentrate to a 99.95% uncoated SPG (spheronised, purified graphite) which is very near to what is used in the lithium-ion battery as graphite content.
Ultimately Blencowe is seeking offtake contracts and this commercial scale test work is designed to provide the samples and the results to qualify Orom-Cross product for these contracts, which themselves form an integral part of the DFS.
Other work continues within Uganda on infrastructure, community relations, environmental updates and all other key aspects of the DFS, and Blencowe remains working towards end-2024 as the delivery date for the DFS – subject to all necessary funding received to deliver as such.
Specialist technical work has also been underway in this period in the USA, considering the beneficiation of Orom-Cross concentrates to various high end products, up to 99.99% which is military grade. To date all work has been successful and provided evidence Orom-Cross has one of the most pure concentrates and upgraded products and this will bode well in future offtake discussions.
Despite all of this progress the Company is facing macro-challenges and the UK market remains flat, which has a direct impact on both the share price and market value. Blencowe will continue to market its achievements and remains positive on the medium and longer term outlook for graphite. We will continue to build our project and add value as this will ultimately be significant as demand continues to rise, while supply of graphite (particularly high quality) remains static.
We thank our shareholders and other stakeholders for their continued support and we look forward to continuing to kick goals ahead to deliver the DFS and success for the Company.
Mike Ralston
Chief Executive Officer
Responsibility Statement of the Directors in respect of the Interim Report
The Directors are responsible for preparing the Interim Financial Statements in accordance with applicable law and regulations. In addition, the Directors have elected to prepare the Interim Financial Statements in accordance with International Financial Reporting Standards (“IFRSs”), as adopted by the United Kingdom (“UK”).
The Interim Financial Statements are required to give a true and fair view of the state of affairs of the Group and of the profit or loss of the Group for that period.
In preparing these Interim Financial Statements, the Directors are required to:
· select suitable accounting policies and then apply them consistently;
· present information and make judgements that are reasonable, prudent and provides relevant, comparable and understandable information;
· provide additional disclosures when compliance with the specific requirements in IFRS is insufficient to enable users to understand the impact of particulars transactions, other events and conditions on the entity’s financial position and financial performance; and
· make an assessment of the Group’s ability to continue as a going concern.
The Directors are responsible for keeping proper accounting records that are sufficient to show and explain the Group’s transactions and disclose with reasonable accuracy at any time its financial position of the Group to enable them ensure that the financial statements comply with the requirements of the Companies Act 2006. They have general responsibility for taking such steps as are reasonably open to them to safeguard the assets of the Group and to prevent and detect fraud and other irregularities.
The Directors are responsible for the maintenance and integrity of the corporate and Interim Financial Statements. Legislation governing the preparation and dissemination of Interim Financial Statements may differ from one jurisdiction to another.
We confirm that to the best of our knowledge:
· the Interim Financial Statements, prepared in accordance with International Financial Reporting Standards as adopted by the UK, give a true and fair view of the assets, liabilities, financial position and profit or loss of the Group for the period;
· the Director’s report includes a fair review of the development and performance of the business and the position of the group, together with a description of the principal risks and uncertainties that they face; and
· the interim report and financial statements, taken as a whole, are fair, balanced and understandable and provide the information necessary for shareholders to assess the group’s performance, business model and strategy.
Consolidated Statement of Comprehensive Income for the six month period ended 31 March 2024
6 months ended 31 Mar 2024 |
6 months ended 31 Mar 2023 |
12 months ended 30 Sep 2023 |
||
(Unaudited) |
(Unaudited) |
(Audited) |
||
Notes |
GBP |
GBP |
GBP |
|
|
|
|
||
Exploration costs |
(23,669) |
(16,642) |
(53,347) |
|
Administrative fees and other expenses |
5 |
(682,486) |
(446,424) |
(1,298,872) |
Operating loss |
|
(706,155) |
(463,066) |
(1,352,219) |
|
|
|
||
Finance costs |
(19,685) |
(23,010) |
(45,748) |
|
Loss before tax |
|
(725,840) |
(486,076) |
(1,397,967) |
|
|
|
||
Income tax |
– |
– |
– |
|
|
|
|
||
Loss after tax |
|
(725,840) |
(486,076) |
(1,397,967) |
|
|
|
|
|
Other comprehensive income |
|
|
|
|
Exchange differences on translation of foreign operation |
|
64,153 |
7,807 |
31,282 |
Other comprehensive income, net of tax |
|
64,153 |
7,807 |
31,282 |
|
|
|
|
|
Total comprehensive loss |
|
(661,687) |
(478,269) |
(1,366,685) |
|
|
|
|
|
Basic and diluted loss per share (pence) |
10 |
(0.31) |
(0.28) |
(0.70) |
There was no other comprehensive income for the period ended on 31 March 2024.
The accompanying notes on form an integral part of the Interim Financial Statements.
Consolidated Statement of Financial Position as at 31 March 2024
|
As at 31 Mar 2024 |
As at 31 Mar 2023 |
As at 30 Sept 2023 |
|
|
(Unaudited) |
(Unaudited) |
(Audited) |
|
Notes |
GBP |
GBP |
GBP |
|
|
|
|
|
|
Non-Current Assets |
6 |
7,061,967 |
7,065,820 |
7,604,564 |
|
|
|
|
|
Current assets |
||||
Trade and other receivables |
7 |
113,470 |
135,901 |
31,863 |
Cash and cash equivalents |
444,991 |
130,740 |
129,853 |
|
Total current assets |
|
558,461 |
266,641 |
161,716 |
Total assets |
7,620,428 |
7,332,461 |
7,766,280 |
|
Current liabilities |
||||
Creditors: Amounts falling due within one year |
8 |
(1,238,944) |
(414,843) |
(1,076,169) |
Total current liabilities |
|
(1,238,944) |
(414,843) |
(1,076,169) |
Non-current liabilities |
||||
Surface liabilities |
9 |
(783,549) |
(785,520) |
(818,915) |
Total liabilities |
(2,022,493) |
(1,200,363) |
(1,895,084) |
|
Net assets |
|
5,597,935 |
6,132,098 |
5,871,196 |
Equity |
||||
Share capital |
12 |
1,377,801 |
1,275,066 |
1,338,566 |
Share premium |
12 |
8,986,590 |
8,099,579 |
8,637,399 |
Warrants reserves |
428,342 |
402,148 |
428,342 |
|
Translation reserve |
94,892 |
7,264 |
30,739 |
|
Retained earnings |
(5,289,690) |
(3,651,959) |
(4,563,850) |
|
Total equity |
|
5,597,935 |
6,132,098 |
5,871,196 |
The accompanying form an integral part of the Interim Financial Statements.
|
Share capital |
Share premium |
Share option reserves |
Retained earnings |
Translation reserve |
Total equity |
GBP |
GBP |
GBP |
GBP |
GBP |
GBP |
|
Balance as at 30 Sep 2022 |
1,181,316 |
7,480,829 |
402,148 |
(3,165,883) |
(543) |
5,897,867 |
Total comprehensive loss for 6 months |
|
|
|
|
|
|
Loss for the period |
– |
– |
– |
(486,076) |
– |
(486,076) |
Total comprehensive loss |
– |
– |
– |
(486,076) |
– |
(486,076) |
Contributions from equity holders |
||||||
New shares issued |
93,750 |
656,250 |
– |
– |
– |
750,000 |
Share issue costs |
– |
(37,500) |
– |
– |
– |
(37,500) |
Exchange differences on translation |
– |
– |
– |
– |
7,807 |
7,807 |
Total contributions from equity holders |
93,750 |
618,750 |
– |
– |
7,807 |
720,307 |
Balance as at 31 Mar 2023 |
1,275,066 |
8,099,579 |
402,148 |
(3,651,959) |
7,264 |
6,132,098 |
|
|
|
|
|
|
|
Total comprehensive loss for 6 months |
|
|
|
|
|
|
Loss for the period |
– |
– |
– |
(911,891) |
– |
(911,891) |
Total comprehensive loss |
– |
– |
– |
(911,891) |
– |
(911,891) |
Contributions from equity holders |
|
|
|
|
|
|
New shares issued |
63,500 |
571,500 |
– |
– |
– |
635,000 |
Share issue costs |
– |
(33,680) |
– |
– |
– |
(33,680) |
Warrants reserve |
– |
– |
– |
– |
– |
– |
Exchange differences on translation of foreign operations |
– |
– |
26,194 |
– |
23,475 |
49,669 |
Total contributions from equity holders |
63,500 |
537,820 |
26,194 |
– |
23,475 |
650,989 |
|
|
|
|
|
|
|
Balance as at 30 Sep 2023 |
1,338,566 |
8,637,399 |
428,342 |
(4,563,850) |
30,739 |
5,871,196 |
Consolidated Statement of Changes in Equity for the six month period ended 31 March 2024
Total comprehensive loss for 6 months |
||||||
Loss for the period |
– |
– |
– |
(725,840) |
– |
(725,840) |
Total comprehensive loss |
– |
– |
– |
(725,840) |
– |
(725,840) |
Contributions from equity holders |
|
|
|
|
|
|
New shares issued |
39,235 |
353,115 |
– |
– |
– |
392,350 |
Share issued costs |
– |
(3,924) |
– |
– |
– |
(3,924) |
Exchange differences on translation of foreign operations |
– |
– |
– |
– |
64,153 |
64,153 |
Total contributions from equity holders |
39,235 |
349,191 |
– |
– |
64,153 |
452,579 |
Balance as at 31 Mar 2024 |
1,377,801 |
8,986,590 |
428,342 |
(5,289,690) |
94,892 |
5,597,935 |
The accompanying notes on form an integral part of the Interim Financial Statements.
Consolidated Statement of Cash Flows for the six month period ended 31 March 2024
As at 31 Mar 2024 |
As at 31 Mar 2023 |
As at 30 Sept 2023 |
||
(Unaudited) |
(Unaudited) |
(Audited) |
||
Notes |
GBP |
GBP |
GBP |
|
Operating activities |
|
|
|
|
Loss after tax |
(725,839) |
(486,076) |
(1,397,967) |
|
Depreciation |
– |
104 |
– |
|
Finance costs |
19,685 |
23,010 |
45,748 |
|
Adjustment to Surface Liability |
– |
– |
– |
|
Share issue/warrant cost |
– |
– |
26,194 |
|
Unrealised currency translation |
126,864 |
261,566 |
182,264 |
|
Changes in working capital |
||||
Decrease/(increase) in trade and other receivables |
7 |
(81,607) |
(50,054) |
53,984 |
Increase/(decrease) in trade and other payables |
8 |
162,775 |
(39,568) |
272,664 |
Net cash flows from operating activities |
|
(498,122) |
(291,018) |
(817,113) |
Investment activities |
||||
Purchase of fixed assets |
– |
(748) |
– |
|
Investment in exploration assets |
(1,175,345) |
(621,988) |
(713,848) |
|
Net cash flows from investment activities |
(1,175,345) |
(622,736) |
(713,848) |
|
Financing activities |
|
|||
DFC Government grant |
6 |
1,600,178 |
– |
– |
Shares issued (net of issue cost) |
388,427 |
697,500 |
1,313,820 |
|
Net cash flows from financing activities |
1,988,605 |
697,500 |
1,313,820 |
|
Increase in cash and short-term deposits |
315,138 |
(216,254) |
(217,141) |
|
Cash and short-term deposits brought forward |
129,853 |
346,994 |
346,994 |
|
Cash and cash equivalents at end of period |
|
444,991 |
130,740 |
129,853 |
The accompanying notes form an integral part of the Interim Financial Statements.
Notes to the Financial Statements for the six month period ended 31 March 2024
1. General
Blencowe Resources Plc (the “Company”) is a public limited company incorporated and registered in England and Wales on 18 September 2017 with registered company number 10966847 and its registered office situated in England and Wales at 167-169 Great Portland Street, Fifth Floor, London, England W1W 5PF.
The Group did not earn any trading income during the period under review but incurred expenditure in developing its principal assets.
The Consolidated Interim Financial Statements of the Company for the six month period ended 31 March 2024 comprise the financial statements of the Company and its subsidiaries (together referred to as the “Group”).
2. Accounting Policies
Basis of preparation
The Interim Financial Statements of the Group are unaudited condensed financial statements for the six month period ended 31 March 2024.
The accounting policies applied by the Group in these Interim Financial Statements, are the same as those applied by the Group in its consolidated financial statements and have been prepared on the basis of the accounting policies applied for the financial year to 30 September 2023 which have been prepared in accordance with IFRS as adopted by UK. The Group Financial Statements have been prepared using the measurement bases specified by IFRS each type of asset, liability, income and expense.
The Group Financial Statements are presented in GBP, which is the Group’s functional currency. All amounts have been rounded to the nearest pound, unless otherwise stated.
Government grants
This is the first reporting period the Group is recognising government grants. Government grants are recognized once the entity has complied with conditions attaching to them and they have been received. Governments grants are accounted for using the capital approach under which a grant is recognized outside the profit and loss. Government grants related to assets, are presented in the statement of financial position by deducting the grant in arriving at the carrying amount of the asset. The grant is recognized in profit or loss over the life of a depreciable asset as a reduced depreciation expense.
Comparative figures
The comparative figures have been presented as the Group Financial Statements cover the 6 month period ended 31 March 2023 and the 12 month period ended 30 September 2023. During 2024, the Group discovered that share premium had been erroneously classified as share capital and administration expenses captured as share issue costs for interim accounts as at 31 March 2023. Refer to Note 12.
3. Critical accounting estimates and judgments
In preparing the Group’s Interim Financial Statements, the Directors have to make judgments on how to apply the Group’s accounting policies and make estimates about the future. The Directors do not consider there to be any critical judgments that have been made in arriving at the amounts recognised in the Group Financial Statements.
4. Significant accounting policies
The accounting policies adopted are consistent with those followed in the preparation of the annual financial statements of Blencowe Resources Plc for the year ended 30 September 2023. A copy of these financial statements is available on the Group website at https://blencoweresourcesplc.com.
5. Administrative fee and other expenses
|
6 months ended 31 Mar 2024 |
6 months ended 31 Mar 2023 |
12 Months ended 30 Sep 2023 |
|
(Unaudited) |
(Unaudited) |
(Audited) |
|
GBP |
GBP |
GBP |
Directors’ remuneration |
69,857 |
70,023 |
140,051 |
Professional fees |
80,001 |
121,692 |
226,471 |
Salaries |
75,000 |
75,000 |
150,000 |
Listing fees |
20,933 |
18,218 |
41,123 |
Audit fees |
33,498 |
21,644 |
35,000 |
Share issue/warrant cost |
– |
– |
26,194 |
Administration fees |
23,500 |
23,500 |
47,000 |
Sponsorship |
5,690 |
– |
– |
Broker fees |
18,434 |
20,500 |
41,000 |
Travelling expenses |
11,034 |
7,959 |
16,852 |
Ugandan taxes |
342,751 |
– |
392,425 |
Miscellaneous fees |
4,445 |
87,888 |
72,625 |
Royalties |
1,244 |
– |
– |
Foreign currency (gain)/loss |
(3,901) |
– |
110,131 |
Total |
682,486 |
446,424 |
1,298,872 |
The Group had two employees who are key management personnel and three Directors. The Directors and the key management personnel’s remuneration related solely to short term employee benefits.
6. Non-Current assets
For the period ended 31 March 2024 intangible assets represents capitalised costs associated with the Group’s exploration, evaluation and development of mineral resources net of any Government grants received.
|
6 months ended 31 Mar 2024 (Unaudited) GBP |
6 months ended 31 Mar 2023 (Unaudited) GBP |
12 months ended 30 Sept 2023 (Audited) GBP |
Exploration assets |
8,662,145 |
7,065,176 |
7,604,564 |
Property, Plant and Equipment |
– |
644 |
– |
Grant from US Government (Refer below) |
(1,600,178) |
– |
– |
Total |
7,061,967 |
7,065,820 |
7,604,564 |
The company signed a US$5 million agreement with the U.S. International Development Finance Corporation (“DFC”) in order to provide substantial funding for the Orom Cross Definitive Feasibility Study programme, via a Technical Assistance Grant (“TAG”). The DFC is a proxy for the US Government which funds the organisation and ultimately sets its vision, parameters and funding distribution. DFC payments will be made as agreed feasibility study milestones are achieved. As part of the US$5 million Technical Assistance Grant (“TAG”) the DFC has a right of first refusal on commercial terms to arrange project financing for the Orom-Cross project, which may deliver Blencowe with a full funded solution to bring Orom-Cross into production with support from a major financial institution. The agreement is subject to various events of default.
7. Trade and other receivables
|
6 months ended 31 Mar 2024 |
6 months ended 31 Mar 2023 |
12 Months ended 30 Sep 2023 |
|
(Unaudited) |
(Unaudited) |
(Audited) |
|
GBP |
GBP |
GBP |
Other receivables |
35,166 |
21,526 |
9,421 |
Prepayments |
78,304 |
114,375 |
22,442 |
Total |
113,470 |
135,901 |
31,863 |
8. Creditors: Amounts falling due within one year
|
6 months ended 31 Mar 2024 |
6 months ended 31 Mar 2023 |
12 Months ended 30 Sep 2023 |
|
(Unaudited) |
(Unaudited) |
(Audited) |
|
GBP |
GBP |
GBP |
Payables |
707,912 |
103,980 |
644,585 |
Surface liabilities (Note 9) |
– |
143,036 |
– |
Accruals and provision |
194,352 |
167,827 |
39,159 |
Ugandan taxes |
336,680 |
– |
392,425 |
Total |
1,238,944 |
414,843 |
1,076,169 |
9. Surface liabilities
Blencowe Resources Uganda Limited, the Company’s subsidiary entered into an agreement for surface rights over the land in the mineral area of the licence. The land owners granted Blencowe Resources Uganda Limited a 49 year lease over an area. The liability to the land owners is to be paid in 8 instalments at defined dates with the final payment due in 2035.
|
6 months ended 31 Mar 2024 |
6 months ended 31 Mar 2023 |
12 Months ended 30 Sep 2023 |
|
(Unaudited) |
(Unaudited) |
(Audited) |
|
GBP |
GBP |
GBP |
Total payable at the beginning of the period |
818,915 |
978,255 |
978,255 |
Utilisation |
– |
– |
(148,468) |
Interest charged during the period |
19,685 |
23,010 |
45,748 |
Exchange loss on valuation |
(55,051) |
(72,709) |
(56,620) |
Total payable as at period end |
783,549 |
928,556 |
818,915 |
|
|
|
|
Analysis between current and non-current liability |
|
|
|
Payable within 12 months |
– |
143,036 |
– |
Payable after 12 months |
783,549 |
785,520 |
818,915 |
|
783,549 |
928,556 |
818,915 |
The value of the lease is measured at the present value of the contractual payments due to the lessor
over the lease term, with the discount rate of 5%.
10. Loss per share
The calculation of the basic and diluted loss per share is based on the following data:
6 months ended 31 Mar 2024 |
6 months ended 31 Mar 2023 |
12 Months ended 30 Sep 2023 |
|
(Unaudited) |
(Unaudited) |
(Audited) |
|
Earnings |
GBP |
GBP |
GBP |
Loss from continuing operations for the period attributable to the equity holders of the Group |
(661,687) |
(478,269) |
(1,397,967) |
Number of shares |
|||
Weighted average number of Ordinary Shares for the purpose of basic and diluted earnings per share |
|||
210,540,876 |
168,803,923 |
200,041,594 |
|
Basic and diluted loss per share (pence) |
(0.31) |
(0.28) |
(0.70) |
There are no potentially dilutive shares in issue.
11. Related party transactions
The are no related party transactions during the period except for the Directors’ remuneration, which have been disclosed in note 5.
Sam Quinn is a director and shareholder of the Company and a Director of Lionshead Consultants Limited. During the period, Lionshead Consultants Limited charged fees for consultancy fees of £18,000 (31 March 2023: £18,000 and 30 Sep 2023: £36,000).
12. Reclassification
During 2024, the Group discovered that share premium had been erroneously classified as share capital and administration expenses captured as share issue costs for interim accounts as at 31 March 2023. These errors has been corrected by restating each of the affected financial statement line items for prior periods. The following table summarises the impact on the Group’s consolidated accounts.
Impact of reclassification |
|||
As previously reported |
Restatement |
As restated |
|
|
GBP |
GBP |
GBP |
Total assets |
7,332,461 |
– |
7,332,461 |
Total liabilities |
(1,215,363) |
15,000 |
(1,200,363) |
Net assets |
6,117,098 |
15,000 |
6,132,098 |
Share capital |
1,931,316 |
(656,250) |
1,275,066 |
Share premium |
7,428,329 |
671,250 |
8,099,579 |
Warrants reserve |
402,148 |
– |
402,148 |
Translation reserve |
7,264 |
– |
7,264 |
Retained earnings |
(3,651,959) |
– |
(3,651,959) |
Total Equity |
6,117,098 |
15,000 |
6,132,098 |
There is no material impact on the Group’s basis or diluted earnings per share and no impact on the total operating, investing or financing cashflows for the half year ended 31 March 2023.
13. Events after the reporting date
On 10 April 2024, the Company announced the receipt of its third tranche US$1 million funding from the United States International Development Finance Corporation (“DFC”). This payment, representing a further 20% of the full US$5 million DFC grant further supports the ongoing Orom-Cross Definitive Feasibility Study (“DFS”) costs, bringing the total received to US$3 million since the agreement was signed in Sept 2023. The DFC is the primary US Government finance institution set up to provide financially sound solutions for private sector initiatives pertaining to critical challenges facing the world.
#BRES Blencowe Resources PLC – Annual Financial Report
Blencowe Resources Plc, the natural resources company focused on the development of the Orom-Cross Graphite Project in Uganda, is pleased to announce its audited financial results for the year ended 30 September 2023 (the “Annual Report”) and it’s notice of Annual General Meeting (“Notice of AGM”).
The Annual Report which includes an unqualified audit report and audited Financial Statement for the year ended 30 September 2023 & The Notice of AGM and the associated Form of Proxy will be made available on the Company’s website at www.blencoweresourcesplc.com. Hard copies will be posted to the Company’s shareholders.
For further information, please contact:
Blencowe Resources Sam Quinn
|
Tel: +44 (0) 1624 681 250 info@blencoweresourcesplc.com
|
Investor Enquiries Sasha Sethi |
Tel: +44 (0) 7891 677 441
|
Tavira Financial Limited Jonathan Evans |
Tel: +44 (0)20 7100 5100 jonathan.evans@tavirasecurities.com
|
First Equity Limited Jason Robertson |
Tel: +44 (0)203 192 1733 |
Chief Executive Officer’s Statement for the period ended 30 September 2023
Shareholders and Stakeholders,
It gives me great pleasure to reflect on another year of progress within Blencowe and our continued efforts to unlock the value sitting in our Orom-Cross graphite project in Uganda. This project remains one of the largest, highest quality graphite projects in the world and in a market which is forecast to demand exponential tonnage of graphite ahead, in particular to deliver the huge number of batteries to power electric vehicles and store renewable energy, we are operating in very exciting times.
Our main focus of energy and efforts this past year have been in commencing the Definitive Feasibility Study (DFS) which is the last major study required prior to investment decision, and one that requires a lot more work and cost than the previous Scoping or Pre-Feasibility Studies. The DFS started in the early calendar year and was expected to take 12 months, but longer than anticipated time taken to secure necessary funding has meant the DFS will only be completed by end of 2024. The DFS requires four major thrusts; firstly, mining and infrastructure development at site; secondly revised environmental impact studies to extend the previous EIS that was done in conjunction with our mining license award in 2019; thirdly bulk sample testing in China to ultimately secure offtake contracts; and fourthly, providing a full project funding solution, for the DFS costs themselves but thereafter to implement the strategy and build the mine.
As the DFS has progressed a fifth element has now been added, which is downstream processing of graphite from a concentrate to a purified product. This is being considered as a means to significantly enhance the overall value of the project.
I am pleased to report that all DFS work to date has yielded positive results, with no exceptions. Earlier in the calendar year we mined 100 tonnes of material from Orom-Cross and shipped this to China where it underwent commercial scale testing to show that we can process and deliver the same high quality end concentrate from a much larger quantity than we had previously proven we could deliver from lab-scale testing. This pilot testing in China has been very successful and by showcasing our product over there we have also opened many doors for future relationships; in simple terms our product is well received there which is good as China accounts for the vast majority of the graphite market today. We are using very experienced partners to build these relationships in China, experts who have taken other graphite companies through this same qualification process, so we are confident we will end up with a good end result from this in 2024. In order to seek tier one partnerships for offtake we are now embarking on a further 600 tonne bulk sample to go through the same pilot testing procedure over the next six months and if successful this will hopefully complete our pre-qualification process and allow us to move to negotiate initial offtake agreements which are vital to the DFS.
Work continues in Uganda on all facets of infrastructure and environment, and we are building a strong team there to take ownership of in-country requirements. Government of Uganda support remains firm as does local community support.
The process to find a tier one strategic funding partner has taken us longer than anticipated but has ultimately borne exceptional results, as the Company was able to sign a Technical Assistance Grant with the US International Development Funding Corporation (DFC) in September 2023 for a US$5 million grant to Blencowe for DFS costs, as well as DFC mandated as lead partner to help provide a full project funding solution ahead. Having the US Government as our strategic partner has obvious benefits and we are very proud to be the first and only graphite company that DFC have partnered with to date in this regard. Whilst this took time to lock down this grant it was absolutely worth the wait and Blencowe now has a strong funding partner ahead which is the envy of many of our peers in the graphite market.
The shift in focus to consider further downstream processing is gathering momentum, and this could have a colossal impact on the value that Orom-Cross brings to Blencowe. Whilst mining and processing graphite to a 96% concentrate was proven to be a profitable venture in the PFS we have come to realise that further processing of that concentrate to a 99.95% purified product can yield considerably higher margins and Blencowe is now considering all options how it can get involved in this downstream market. There is substantial IP (intellectual property) involved which is held by existing processing companies so any such a move would involve partnering with one or more of these processing experts, but work is underway to consider several alternatives.
Further work has been completed using international technical experts to ascertain the quality of Orom-Cross graphite as it upgrades from 96% concentrate to a purified 99.95% end product, and I am pleased to say the results have been outstanding, with Orom-Cross having passed with flying colours. At the end of the day each graphite project is unique, with inherent chemical characteristicst hat are different to each project, and which largely define the quality of the end product and therefore price and demand for these end products. As we continue to test Orom-Cross through to 99.95% purified product we continue to learn of its exceptional chemical properties and these characteristics will ultimately be the advantage that helps shape key relationships, offtake partners and contracts.
I would like to reach out to all the consultants, partners, and other relationships we have built to thank all of them for their efforts, including our internal management team. We are in very exciting times as the green energy revolution gathers pace and the graphite market is evolving fast due to a variety of factors, including geopolitics. Each and every one of these partnerships is critical to our success ahead and we value their expertise and support.
I would also like to thank our shareholders and the wider market for your support, and in particular our major shareholders who have stuck by us through what have been challenging market conditions. We offer the ability to be part of something unique as we develop this exceptional project, and we hope that we can continue to justify your faith and your investment.
Mike Ralston
Chief Executive officer
The Directors present the Strategic Report for the year ended 30 September 2023.
Results
The results are set out in the Consolidated Statements of Comprehensive Income on page 29. The total comprehensive loss attributable to the equity holders of the Group for the period was £1,366,685 (2022: £1,089,679).
The Group paid no distribution or dividends during the period.
Business model, review of the business and future developments
The Group’ principal activity is the exploration of Orom-Cross Graphite Project in Northern Uganda, which it owns through its 100% subsidiary Consolidated African Resources Limited ‘CARU’.
The Group’s aim is to create value for shareholders through the discovery and development of economic mineral deposits. The Group’s strategy is to continue to progress the development of its existing project in Uganda and to evaluate its existing and new mineral resource opportunities.
The Group’s business is directed by the Board and is managed on a day-to-day basis by the Executive Chairman, Cameron Pearce. The Board monitors compliance with objectives and policies of the Group through performance reporting, budget updates and periodic operational reviews.
Key performance indicators (KPIs)
Financial KPIs
Results for the year
With no income in the year the Group continues to monitor the loss before tax to ensure the continued viability of the Group and ability to continue to develop the Orom-Cross Graphite Project. The Group has made a loss before tax of £1,397,967 for the year ended 30 September 2023 (2022: loss before tax of £1,085,474).
Exploration expenditure – funding and development costs
At this stage in the Group’s development, the Group is focusing on financing and continued development of the Orom-Cross Graphite Project. Therefore, the funding and development costs of Orom-Cross Graphite project have been chosen as Key Performance Indicators.
The Group incurred £1,190,977 (2022: £1,423,236) of capitalised exploration costs. These exploration costs are in line with the Board expectations.
In 2023 the Group raised funds of £1,313,820 net of issue costs (2022: £2,628,748) from the equity markets. Please see note 20 for further details of the funds raised after the year end.
At 30 September 2023 the Group had a cash balance of £129,853 (2022: £346,994).
Employees
There were two employees during the year apart from the directors, the Chief Executive Officer (“CEO”) and the Chief Operating Officer (“COO”), who are the key management personnel. All current members of the Board and the key management personnel are males. For more information about the Group’s key management personnel see note 7.
Social, Community and Human Rights Issues
The Orom-Cross Graphite Project is still at an early stage of project development and further consideration will need to be given to social, community and human rights issues affecting the Project. Currently a key consideration is that under Ugandan law the Company is required to rehabilitate the area affected by the mining activities. Accordingly, there will be a potential cost associated with undertaking this obligation. At this time, although the Group continues to explore and test the minerals, the land has not been affected and therefore the Group has not accounted for any costs associated with the rehabilitation of the area.
On 10 September 2022 CARU signed a revised agreement with the local communal land association of Locomo village for the land surface rights and has agreed to help provide local education and sensitization of the local communities in Akurumo parish on the opportunities and advantages of mining graphite. CARU will give employment priorities to the local capable members of Akurumo parish.
Since the acquisition of CARU the Group has donated to local causes, such as a scholarship programme and to fight against COVID-19. The Group will continue to donate to the local communities around the region of Uganda in which the Project Licences are located.
Principal risks and uncertainties and risk management
The Group operates in an uncertain environment and is subject to a number of risk factors. The Directors have carried out a robust assessment on the principal risks facing the Group, including those that threaten its business model, future performance, solvency or liquidity.
The Group continues to monitor the principal risks and uncertainties with the help of specialists to ensure that any emerging risk are identified, managed and mitigated. There has been no significant impact to the Group from the Russia-Ukraine conflict and the Israel-Palestine conflict.
Geological risks
On 19 July 2022, the Group completed the pre- feasibility study for the Orom-Cross graphite project and a net present value (post tax) assessment of $482million has been estimated from the project. The pre-feasibility study indicates a robust, long-term, and profitable mining operation at Orom-Cross. The Pre-feasibility study was managed by leading graphite technical experts Battery Limits Pty Limited (Australia), who have delivered several other graphite project feasibility study in the past. The estimated production per annum will be 36,000tpa as 96-97% end products and increasing this to 147,000tpa in stages. It is estimated that 50% of the product is +100 to +50 mesh fractions. The pre-feasibility study estimated a US$1,307/t weighted average selling price for a basket of end products and US$499/t operating costs, underlining one of the lowest cost graphite projects worldwide. On 26 September 2022 the Group announced that it had commenced the definitive feasibility study with completion date 2H-2023.
On 6 December 2022, the Group completed the metallurgical test work on substantially up-scaled quantities of Orom-Cross composite mix. The additional metallurgical test work on Orom-Cross graphite continues to deliver a high-quality grade graphite concentrate. The program was designed to deliver the following objectives:
1. Confirm a 95-97% total graphite content, pure concentrate with low impurities.
2. Confirm 90% recovery is achievable for this concentrate.
3. Confirm the liberation process to maintain a high percentage of Jumbo/XL/Large flakes within concentrate.
4. Confirm process flow diagram for plant design as part of the Definitive Feasibility Study.
5. Deliver bulk concentrate samples to allow Blencowe to initiate discussions with potential off-take partners.
On 11 January 2023 the Ugandan Government approved a landmark one-off permit for Blencowe to export bulk sample graphite from Orom-Cross for key Metallurgical final testing. 100 tonnes of bulk samples were mined, and fast track delivered to China by air freight for initial off -site testing with a Chinese experienced graphite processing specialist Jilin Huiyang New Material Technology Company Limited. Blencowe also send an additional 5kg of concentrate to Chicago-based graphite specialist AET Co, which is a recognized industry expert in SPG (spheronised purified graphite) and expandability testing.
On 23 January 2023, the group appointed a leading firm from Perth, CPC Engineering to lead, develop and sign off the Definitive Feasibility study.
The Group uses advisors with specialist knowledge in mining and related environmental management for reducing the impacts of environmental risk.
Government regulation and political risk
The Group’s operating activities are subject to laws and regulations governing expropriation of property, health and worker safety, employment standards, waste disposal, protection of the environment, mine development, land and water use, prospecting, mineral production, exports, taxes, labour standards, occupational health standards, toxic wastes, the protection of endangered and protected species and other matters. While the Group believes that it is in substantial compliance with all material current laws and regulations affecting its activities, future changes in applicable laws, regulations, agreements or changes in their enforcement or regulatory interpretation could result in changes in legal requirements or in the terms of existing permits and agreements applicable to the Group or its properties, which could have a material adverse impact on the Group’s current operations or planned exploration and development projects. Where required, obtaining necessary permits and licences can be a complex, time consuming process and the Group cannot assure whether any necessary permits will be obtainable on acceptable terms, in a timely manner or at all. The costs and delays associated with obtaining necessary permits and complying with these permits and applicable laws and regulations could stop or materially delay or restrict the Group from proceeding with any future exploration or development of its properties. Any failure to comply with applicable laws and regulations or permits, even if inadvertent, could result in interruption or closure of exploration, development or mining operations or material fines, penalties or other liabilities.
The Orom-Cross Graphite Project is located in Uganda. The Group’s activities may be affected in varying degrees by political stability and governmental regulations. Any changes in regulations or shifts in political attitudes in the country or any other countries in which the Group may operate are beyond the control of the Group and may adversely affect its operations. To mitigate this risk, the Board continues to review any changes on the government regulations and the political stability in Uganda.
Pricing risk
The development and success of any project of the Group will be primarily dependent on the future prices of graphite. The graphite prices are subject to significant fluctuation and are affected by a number of factors which are beyond the control of the Group. Such factors include, but are not limited to exchange rates, fluctuations in the value of the United States dollar and foreign currencies, global and regional supply and demand, and political and economic conditions. The price of graphite and other commodities have fluctuated widely in recent years, and future price declines could cause any future development of and commercial production from the Group’s property to be impracticable. Although the Group expects to have sufficient working capital for the Working Capital Period, depending on the price of graphite, projected cash flow from planned mining operations may not be sufficient for future operations and the Group could be forced to discontinue any further development and may lose its interest in, or may be forced to sell, some or all of its properties. Future production from the Orom-Cross Graphite Project is dependent on the production of graphite that is adequate to make the project economically viable. The Board regularly monitors the prices of graphite and is prepared to raise further capital if it is required.
Commodity and currency risk
As the Groups’ potential earnings will be largely derived from the sale of graphite, the Group’s future revenues and cash flows will be impacted by changes in the prices and available market of this commodity. Any substantial decline in the price of graphite or in transport or distribution costs may have a material adverse effect on the Group.
Commodity prices fluctuate and are affected by numerous factors beyond the control of the Group. These factors include current and expected future supply and demand, forward selling by producers, production cost levels in major mineral producing centers as well as macroeconomic conditions such as inflation and interest rates.
Furthermore, the international prices of most commodities are denominated in United States dollars while the Group cost base will be in Pounds Sterling and Ugandan Shilling. Consequently, changes in the Pound Sterling and Ugandan Shilling exchange rates will impact on the earnings of the Group. The exchange rates are affected by numerous factors beyond the control of the Group, including international markets, interest rates, inflation and the general economic outlook. The Directors are confident that they have put in place a strong management team capable of dealing with the above issues as they arise.
Financing
On 27 April 2023 the Group announced that it had found a strategic funding partner for the Orom-Cross Graphite project, and this was completed on 22 September 2023. The Development Finance Corporation (DFC) engaged to fund 50% of Project Definitive Feasibility Study costs by way of a technical assistance grant. US International Development Finance Corporation is America’s leading development finance institution that partners with the private sector to provide finance solutions for project development in markets deemed critical. As of 10 October 2023, the Group received $1 million of the $5 million technical grant funding from the Development Finance Corporation. The Group is likely to remain cash flow negative for some time and, although the Directors have confidence in the future revenue earning potential of the Group from its interests in the Orom-Cross Graphite Project, there can be no certainty that the Group will achieve or sustain profitability or positive cash flow from its operating activities. With regards to future capital expenditure on the Orom-Cross Graphite Project, the Company will need to raise additional capital during the next 12 months in order to fully fund completion of the Definitive Feasibility Study.
The Group has been approached by potential strategic partners who may eventually provide an offtake, funding or development scenario for the Orom-Cross graphite project. If this is not successful, the Board may consider stopping the project until further cash can be generated.
Future mineral prices, revenues, taxes, capital expenditures and operating expenses and geological success will all be factors which will have an impact on the amount of additional capital required. Additionally, if the Group acquires further exploration assets or is granted additional permits and/or exploration licences, this may increase its financial commitments in respect of the Group’s exploration activities.
In common with many exploration entities, the Group will need to raise further funds in order to progress the Group from pre-construction phase of its business and eventually into production of revenues.
Environmental and safety
The Orom-Cross Graphite Project is still at an early stage of project development and further consideration will need to be given to environmental and social issues affecting the Orom-Cross Graphite Project. Environmental and safety legislation (e.g. in relation to reclamation, disposal of waste products, protection of wildlife and otherwise relating to environmental protection) may change in a manner that may require stricter or additional standards than those now in effect, a heightened degree of responsibility for companies and their directors and employees and more stringent enforcement of existing laws and regulations. There may also be unforeseen environmental liabilities resulting from both future and historic exploration or mining activities, which may be costly to remedy. Risks may include on-site sources of environmental contamination such as oil and fuel from the mining equipment and rehabilitation of the site upon expiry of the Project Licences. Under Ugandan law the Company is required to rehabilitate the area affected by the mining activities, accordingly there will be a potential cost associated with undertaking this obligation. It is currently unknown what this could be but the funding of this could have a material impact on the Group’s financial position in the future.
If the Group is unable to fully remedy an environmental problem, it may be required to stop or suspend operations or enter into interim compliance measures pending completion of the required remedy. The potential exposure may be significant and could have a material adverse effect on the Group.
The Group has not purchased insurance for environmental risks (including potential liability for pollution or other hazards as a result of the disposal of waste products occurring from exploration and production) as it is not generally available at a price which the Group regards as reasonable.
Environmental management systems are in place to mitigate environmental hazard risks. The Group uses advisors with specialist knowledge in mining and related environmental management for reducing the impacts of environmental risk.
Task Force on Climate -related Financial Disclosures (TCFD)
The Task Force on Climate-related Financial Disclosures was convened by the Financial Stability Board to produce a common global framework for companies to report on how climate change will affect their business.
To help investors and wider stakeholders understand how companies are managing climate related financial risks, the TCFD recommends that companies make disclosures across four key areas, often referred to as the four pillars.
The directors support the initiatives of the TCFD, and has prepared disclosures to a level of detail that the directors consider to be consistent with the TCFD recommended disclosures, and as appropriate to the current position of the Group as an exploration entity.
The directors consider that several of the specific disclosures sought under TCFD recommendations will be less meaningful to users at the current stage of the Company’s Orom-Cross Project and will have greater relevance at the conclusion of the DFS (due to be completed by the end of 2024) and following the commissioning of the Orom-Cross Project.
1. Governance
The Company view climate related risks and opportunities as growing in importance. The Board is ultimately responsible for the oversight and compliance with local environmental laws at its exploration location in Uganda, together with assessment of the impact of climate change on risk to the organisation.
In advance of commissioning the project operations, the Group will establish a Sustainability Committee, comprising the Chairman, the Chief Executive Officer and a non-executive director, that will guide and support the Group’s environmental approach and plans with respect to climate-related matters. The Committee will also consider and set appropriate Group policies that will govern how management assess and manage the risks and opportunities following commissioning.
Management of the group, who are involved with the ongoing DFS are responsible for assessing and managing climate -related risks and opportunities through the current study and will input to plans and assessments related to the ESIA (environmental and social impact assessment) and ESG (environmental, social and governance) components of the study.
2. Strategy
The Group’s project at Orom-Cross is currently in the stage of completing its Definitive Feasibility Study, the outcome of which in 2024 will include more detail and assessment to define the Group’s strategic approach to climate-related matters.
The current global movement towards clean energy and storage solutions, in which graphite forms an integral part, together with technological advances in the use of graphite are an exciting opportunity for the Group to be a significant part of sustainable energy solutions.
3. Risk management
Identification and assessment of climate related risks and opportunities in relation to the Group’s activities is performed by management on an ad-hoc basis. Management have not assessed there to be any significant climate-related risks that impact on the current exploration activity in Uganda.
The Group is currently completing the DFS, which will include ESIA and ESG assessments that will assist management to detail the climate related risks and opportunities relating to development of the project. Identification and mitigation of these risks will be addressed by the planned Sustainability Committee described in the Governance section of this statement.
At this time the Group operates no corporate offices either for the management team, or in Uganda, and has no operational graphite production activity. As such management have assessed that no significant greenhouse gas (GHG) emissions are currently produced.
As the project progresses through the DFS, the risk management framework is somewhat fluid and will be analysed, adapted and expanded as the various study components of the DFS develop. The Group is identifying and developing a ‘leave no trace’ solution to development wherever possible including utilising renewable energy supply and electrification options for operations. These actions will be included in the output of the DFS.
The Group currently employs the foundations of ISO Risk Management standards 31000, and will develop this by engaging in the certification process for this standard. Climate risks will be identified in detail in the ESIA and ESG assessments that form part of the DFS.
Management have not identified any climate-related scenarios that are expected to impact the resilience of the current exploration works performed by the Group. Assessment of different climate scenarios will be included in the works performed for the DFS.
4. Metrics and targets
The Company will define the metrics and performance targets to assess the climate-related risks and opportunities in line with its strategy and risk management processes once the Orom-Cross operation has been commissioned. Initially some of these will be outlined as part of the ESIA and ESG assessments currently being undertaken for the project DFS.
As the current exploration operations of the Group have a minimal physical presence, Greenhouse Gas emissions are not currently recorded. However as part of the ESIA and ESG study works, the Group is developing the systems and reporting standards to track these in preparation for development of the project.
Taxation
Following an inspection by the Ugandan Revenue Authority (URA) of the tax affairs of Consolidated African Resources Uganda (“CARU”) covering the period between January 2014 and December 2022, the Group has incurred a capital gains tax charge of £392,425 as set out in Note 8 to the Financial Statements. This charge related to the acquisition by the Company of CARU in 2019. The amount was chargeable to the former owners, however this was not settled by them and under Ugandan legislation the liability is reclaimable from the acquirer if it cannot be obtained from the seller. Following advice from in-country tax advisors the Company is currently in discussions with the Ugandan Revenue Authority (URA) regarding options available to the Company to either pursue the seller for the tax liability or to seek a reduction or payment plan for the liability.
Section 172 Statement
The Board believes they have acted in a way most likely to promote the success of the Group for the benefit of its members as a whole, as required by section 172.
The requirements of section 172 are or the Board to:
· consider the likely consequences of any decision in the long term,
· act fairly between the members of the Group,
· maintain a reputation for high standards of business conduct,
· consider the interest of the Group’s employees,
· foster the Group’s relationship with suppliers, customers and others, and
· consider the impact of the Group’s operations on the community and the environment.
The Group operates a mineral exploration business, which is inherently speculative in nature and, without regular income, is dependent upon fund-raising for its continued operation. The pre-revenue nature of the business is important to the understanding of the Group by its members, employees and suppliers, and the Directors are as transparent about the cash position and funding requirements as is allowed under LSE regulations.
The principal decisions taken by the Board during the year relate to the ongoing research and development of the Orom-Cross Graphite Project, which since its acquisition in 2020 is still at an early stage of project development. The Board has looked to build upon the information available and the exploration activities carried out by the Subsidiary prior to its acquisition. Through work such as Metallurgical testwork and preliminary economic assessment the board continues to gather information on the long-term viability of the project and the impact on the local community and the environment. The Board have outlined a work program for the future strategy of the Project. In order to carry out its strategy, the company has entered into a number of contracts with providers who are best placed to undertake the necessary research and review.
The Board is ultimately responsible for the direction, management, performance and long-term sustainable success of the Group. It sets the Group’s strategy and objective considering the interest of all its stakeholders. A good understanding of the Company’s stakeholders enables the Board to factor the potential impact of strategic decisions on each stakeholder group into a boardroom discussion. By considering the Company’s purpose, vision and values together with its strategic priorities the Board aims to make sure that its decisions are fair. The Board has always taken decisions for the long term and consistently aims to uphold the highest standards of business conduct. Board resolutions are always determined with reference to the interests of the Company’s employees, its business relationships with suppliers and customers. Wherever possible, local communities are engaged in the geological operations and support functions required for field operations providing much needed employment and wider economic benefits to the local communities. In addition, the Group contributes annually towards a scholarship programme for the local community in Uganda. The Board takes seriously its ethical responsibilities to the communities and environment in which it works. We abide by the local and relevant UK laws on anti-corruption and bribery.
The Group follows international best practice on environmental aspects of our work.
Cameron Pearce
Director
30 January 2024
The Directors submit their report with the audited Financial Statements for the year ended 30 September 2023.
General information
Blencowe Resources Plc (“the Company”), was incorporated as a private Limited Company under the laws of England and Wales with registered number 10966847 on 18 September 2017. On 13 July 2018, the Company was re-registered as a public company under the Companies Act 2006.
Blencowe’s primary focus is on exploration of the Orom-Cross Graphite Project located in Northern Uganda.
Results for the year and distributions
The Group results are set out in the Consolidated Statements of Comprehensive Income. The total consolidated comprehensive loss attributable to the equity holders of the Group for the financial year was £1,366,685 (2022: £1,089,679). The Group received no income, and the full amount of the loss is due to expenses incurred in capital raising (to the extent not deducted from share premium), and general corporate overheads.
The Group paid no distribution or dividends during the financial year (2022: £Nil).
Subsidiary change of name
On 7 March 2023 Blencowe Resources Uganda Limited a 100% owned subsidiary of Blencowe Resources Plc changed its name to Consolidated African Resources Limited.
The Board of Directors
The Directors who held office during the financial year and to the reporting date, together with details of their interest in the shares of the Company at the reporting date were:
|
|
Number of Ordinary Shares |
Percentage of Ordinary Shares |
Sam Quinn |
4,916,667 |
2.35% |
|
Cameron Pearce |
7,516,667 |
3.59% |
|
Alexander Passmore |
1,550,000 |
0.74% |
The Board comprises of one Executive Director and two Non-Executive Directors as detailed below:
Cameron Pearce – Executive Chairman
Cameron Pearce was a founder of the Company and has extensive professional experience in both the Australian and United Kingdom finance industries. In recent times he has provided corporate, strategic, financial and advisory assistance to private and public companies in both Australia and the United Kingdom. Mr Pearce is a member of the Australian Institute of Chartered Accountants and has been in commerce over twenty years holding senior financial and management positions in both publicly listed and private enterprises in Australia, Europe, Asia, Africa and Central America. Mr. Pearce has considerable corporate and international expertise and over the past decade has focussed on mining and exploration activities.
Sam Quinn – Non Executive Director
Sam Quinn is a corporate lawyer with over a decade’s worth of experience in the natural resources sector, in both legal counsel and executive management positions. Mr Quinn was formerly the Director of Corporate Finance and Legal Counsel for the Dragon Group, a London-based natural resources venture capital firm and is currently a partner of Silvertree Partners, a natural resource focussed back office outsourcing business. Mr Quinn has in addition held several management roles for listed and unlisted natural companies and has gained significant experience in the administration, operation, financing and promotion of natural resource companies. Prior to working in the natural resources sector, Mr Quinn worked as a corporate lawyer for Jackson McDonald Barristers & Solicitors in Perth, Western Australia and for Nabarro LLP in London.
Alex Passmore – Non Executive Director
Alex Passmore is an experienced corporate executive with strong financial and technical background. Mr Passmore managed the arrangement of debt for many well-known resources companies and has a wealth of experience in project evaluation. He also managed the WA natural resources business of CBA which comprised a substantial portfolio of loan, hedge, trade finance and working capital products to ASX-listed and multi-national resource companies. Prior to this, Mr Passmore held senior roles at Patersons Securities and was director of corporate finance and head of research. Mr Passmore holds a BSc (Hons) in Geology from the University of Western Australia and a graduate diploma of Applied Finance and Investments from the Institute of Securities Australia.
Directors’ indemnities
To the extent permitted by law and the Articles, the Company has made qualifying third-party indemnity provisions for the benefit of its directors during the year, which remain in force at the date of this report.
Policy for new appointments
Without prejudice to the power of the Company to appoint any person to be a Director pursuant to the Articles the Board shall have power at any time to appoint any person who is willing to act as a Director, either to fill a vacancy or as an addition to the existing Board, but the total number of Directors (other than alternate directors) must not be less than two and must not be more than 15 in accordance with the Articles. Any Director so appointed shall hold office only until the annual general meeting of the Company next following such appointment and shall then be eligible for re-election but shall not be taken into account in determining the number of Directors who are to retire by rotation at that meeting. If not re-appointed at such annual general meeting, he shall vacate office at the conclusion thereof.
Rules for amendments of articles
Directors cannot alter the Company’s Articles unless a special resolution is approved by the shareholders. A special resolution requires at least 75% of a company’s members to vote in favour for it to pass.
Substantial shareholders
The share capital of Blencowe consist of only one class: ordinary shares. Therefore, all of the Company’s shares rank pare passu and no preferential rights apply. No single person directly or indirectly, individually or collectively, exercises control over the Company. The Directors are aware of the following persons, who had an interest in 3% or more of the issued ordinary share capital of the Company as at 30 September 2023:
|
Shareholder |
% of issued share capital of the Company |
|
|
|
Pershing Nominees Limited |
23.91% |
|
Hargreaves Lansdown (Nominees) Limited |
16.46% |
|
|
Interactive investors services Nominees Limited |
9.57% |
|
Lawshare Nominees Limited |
6.08% |
|
Vidacos Nominees Limited |
5.11% |
|
James Brearley Crest Nominees Limited |
4.02% |
|
HSDL Nominees Limited |
3.40% |
The Directors are not aware of any changes in interests between 30 September 2023 and the date of approval of the financial statements.
Financial risk management
The Group’s principal financial instruments comprise cash balances, accounts payable and other receivables arising in the normal course of its operations.
The Group’s objectives when managing capital are to safeguard the Group’s ability to continue as a going concern in order to provide returns for shareholders and benefits for other stakeholders and to maintain an optimal capital structure to reduce the cost of capital. In order to maintain or adjust the capital structure, the Group may adjust the amount of dividends paid to shareholders, return capital to shareholders, issue new shares, or sell assets to reduce debt.
The Group’s activities expose it to a variety of financial risks: market risk, credit risk, liquidity risk and cash flow interest rate risk. See note 18.2 for more information on the financial risk management objectives and policies.
Greenhouse Gas (GHG) Emissions
The energy consumption has not been disclosed as the Group’s consumption is below 40,000 kWh.
Responsibility statement
The Directors are responsible for preparing the Annual Report and the Financial Statements in accordance with applicable law and regulations.
Company law requires the Directors to prepare financial statements for each financial year. Under that law, the Directors have elected to prepare the financial statements in accordance with UK adopted international accounting standards. Under company law, the Directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs and profit or loss of the Company and Group for that period.
In preparing these Financial Statements, the Directors are required to:
· select suitable accounting policies and then apply them consistently;
· make judgements and accounting estimates that are reasonable and prudent;
· state whether UK adopted international accounting standards have been followed, subject to any material departures disclosed and explained in the financial statements; and
· prepare the financial statements on a going concern basis, unless it is inappropriate to presume that the Company will continue in business.
The Directors are responsible for keeping adequate accounting records that are sufficient to show and explain the Company’s transactions and disclose with reasonable accuracy at any time the financial position of the Group to enable them to ensure that the financial statements comply with the requirements of the Companies Act 2006. They are also responsible for safeguarding the assets of the Company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.
The Directors are responsible for preparing the Annual Report in accordance with applicable law and regulations. The Directors consider the Annual Report and the financial statements, taken as a whole, provide the information necessary to assess the Group’s position, performance, business model and strategy and are fair, balanced and understandable.
The Directors are responsible for the maintenance and integrity of the corporate and financial information included on the Company’s website. Legislation in the United Kingdom governing the preparation and dissemination of financial statements may differ from legislation in other jurisdictions.
Directors’ responsibilities pursuant to DTR4
The Directors confirm to the best of their knowledge:
· the financial statements have been prepared in accordance with UK adopted international accounting standards and give a true and fair view of the assets, liabilities, financial position and profit or loss of the Group; and
· the management report includes a fair review of the development and performance of the business and the financial position of the Group, together with a description of the principal risks and uncertainties that they face.
Embed effective risk management, considering both opportunities and threats, throughout the organisation
The Directors are responsible for maintaining the Group’s systems of controls and risk management in order to safeguard its assets.
Risk is monitored and assessed by the Board who meet regularly and are responsible for ensuring that the financial performance of the Group is properly monitored and reported. This process includes reviews of annual and interim accounts, results announcements, internal control systems, procedures and accounting policies.
Subsequent events
Please see note 20 for details of the Group’s subsequent events.
Directors’ confirmation
So far as the directors are aware, there is no relevant audit information of which the Group’s auditors are unaware, and they have taken all steps that they ought to have taken as directors in order to make themselves aware of any relevant audit information and to establish that the Group’s auditors are aware of that information.
Auditors
The auditors, Crowe U.K LLP, have expressed their willingness to continue in office and a resolution to reappoint them will be proposed at the Annual General Meeting.
By Order of the Board
Cameron Pearce
Director
30 January 2024
Corporate Governance
The Group recognises the importance of, and is committed to, high standards of Corporate Governance. Whilst the Group is not formally required to comply with the UK Corporate Governance Code 2018, the Group will try to observe, where practical, the requirements of the UK Corporate Governance Code 2018, as published by The Financial Reporting Council.
The Company intends to voluntarily observe the requirements of the UK Corporate Governance Code 2018, save as set out below. As at the date of the financial statements the Directors consider the Group to be in compliance with the UK Corporate Governance Code 2018 with the exception of the following:
· The Company does not comply with the requirements of the UK Corporate Governance Code in relation to the requirement to have a senior independent director and the Audit Committee does not have three independent non-executive directors. The Nomination & Remuneration Committees also do not include independent directors.
· Due to the current size of the company, and the early stages of the Project’s life cycle, the Company has not developed a formal diversity policy, and investment in and rewarding of the workforce. Furthermore, there have been no board evaluations conducted within the year.
· All directors are not subject to annual re-election. Instead at least one third of the current directors are put forward for re-election at each annual general meeting, in accordance with the Company’s Articles of Association.
· Remuneration for the non-executive directors includes share options. The awards are made in accordance with the Company’s remuneration policy.
· The Board does not consider there to be a need for a formal succession plan at this stage, but this will be monitored as the size and complexity of the Company’s activities develop.
As at the date of the financial statements, the Board has a share dealing code that complies with the requirements of the Market Abuse Regulations. All persons discharging management responsibilities (comprising only the Directors at the date of this Document) shall comply with the share dealing code from the date of Admission.
Set below are Blencowe Resources Plc’s corporate governance practices for the year ended 30 September 2023.
Leadership
The Company is headed by an effective Board which is collectively responsible of the long term success of the Company.
The role of the Board – The Board sets the Company’s strategy, ensuring that the necessary resources are in place to achieve the agreed strategic priorities, and reviews management and financial performance. It is accountable to shareholders for the creation and delivery of strong, sustainable financial performance and long-term shareholder value. To achieve this, the Board directs and monitors the Company’s affairs within a framework of controls which enable risks for the future success of the business to be assessed and managed effectively. The Board also has responsibility for setting the Company’s core values and standards of business conduct and for ensuring that these, together with the Company’s obligations to its stakeholders, are widely understood throughout the Company. The Board has a formal schedule of matters reserved which is provided later in this report.
The Company aims to generate and preserve value over the long-term primarily through the development of its principal asset, the Orom-Cross Graphite project in the Republic of Uganda. The Company has previously completed a preliminary feasibility study on the project and is now in the process of completing a definitive feasibility study which will provide a risked and independent project valuation to international standards. The DFS process is rigorous and will result in an examination of all aspects of the project including economic viability, principal risks as well as engineering and geological matters.
Board Meetings – The core activities of the Board are carried out in scheduled meetings of the Board. These meetings are timed to link to key events in the Company’s corporate calendar and regular reviews of the business are conducted. Additional meetings and conference calls are arranged to consider matters which require decisions outside the scheduled meetings. During the year, the Board met on 10 occasions. Any concerns identified that cannot be resolved in these meetings will be documented in written form to the Chairman and recorded in the formal minutes of the Company. In addition to the
Leadership (continued)
Board meetings linked to corporate transactions, the directors consider on an ad hoc, non-formal basis their effectiveness and relevance, and that of management.
Outside the scheduled meetings of the Board, the Directors maintain frequent contact with each other to discuss any issues of concern they may have relating to the Company or their areas of responsibility, and to keep them fully briefed on the Company’s operations.
Matters reserved specifically for Board – The Board has a formal schedule of matters reserved that can only be decided by the Board. The key matters reserved are the consideration and approval of:
· the Group’s overall strategy;
· financial statements and dividend policy;
· management structure including succession planning, appointments and remuneration;
· material acquisitions and disposal, material contracts, major capital expenditure projects and budgets;
· capital structure, debt and equity financing and other matters;
· risk management and internal controls;
· the Group’s corporate governance and compliance arrangements; and
· corporate policies
Summary of the Board’s work in the financial year – During the year, the Board considered all relevant matters within its remit, but focused in particular on exploration and development of the Orom-Cross Graphite Project.
Attendance at meetings:
Member |
|
Meeting attended |
Cameron Pearce |
Executive Chairman |
9 |
Sam Quinn |
Non-Executive Director |
10 |
Alexander Passmore |
Non-Executive Director |
10 |
The Board is pleased with the level of attendance and participation of Directors at Board and committee meetings.
The Chairman, Cameron Pearce, sets the Board Agenda and ensures adequate time for discussion.
Non-executive Directors – The non-executive Directors bring a broad range of business and commercial experience to the Company and have a particular responsibility to challenge independently and constructively the performance of the Executive management (where appointed) and to monitor the performance of the management team in the delivery of the agreed objectives and targets.
Non-executive Directors – Are initially appointed for a term of three years, which may, subject to satisfactory performance and re-election by shareholders, be extended by mutual agreement.
Other governance matters – All of the Directors are aware that independent professional advice is available to each Director in order to properly discharge their duties as a Director. In addition, each Director and Board committee has access to the advice of the Company Secretary.
The Company Secretary – The Company Secretary is FIM Secretaries Limited which is retained on a consultancy basis. FIM Secretaries Limited is available to Directors and advises the Board on UK compliance matters.
Effectiveness
For the period under review the Board comprised of an Executive Chairman and two non-executive Directors.
The Directors are of the view that the Board and its committees consist of Directors with an appropriate balance of skills, experience, independence and diverse backgrounds to enable them to discharge their duties and responsibilities effectively.
The Board believes it has the correct balance of skills, reflecting a broad range of commercial and professional skills across geographies and relevant industries that is necessary to ensure the Company is equipped to deliver its investment objective. Additionally, each Director has experience in public markets.
The Directors and their roles and key personnel are displayed on the Company’s website: Management & Directors – Blencowe Resources (blencoweresourcesplc.com)
Independence – None of the Directors are considered to be independent, as they have shareholdings in the Company as noted on page 11. It is intended that additional Directors will be appointed in future and that independence will be one of the key factors considered at that time. As at the date of this Report no prospective Directors have been identified and no arrangements exist (formal or informal) for the appointment of any other Director.
Appointments – The Board is responsible for reviewing and the structure, size and composition of the Board and making recommendations to the Board with regards to any required changes. The Non-executive directors informally scrutinise and hold to account the performance of management and the Executive Chairman, there are no other Executives on the Board. The Board are satisfied with the current size and composition of the Board and management.
Commitments – All Directors have disclosed any significant commitments to the Board and confirmed that they have sufficient time to discharge their duties.
Induction – All new Directors received an induction as soon as practical on joining the Board.
Conflict of interest – A Director has a duty to avoid a situation in which he or she has, or can have, a direct or indirect interest that conflicts, or possibly may conflict with the interests of the Company. The Board had satisfied itself that there is no compromise to the independence of those Directors who have appointments on the Boards of, or relationships with, companies outside the Company. The Board requires Directors to declare all appointments and other situations which could result in a possible conflict of interest.
Accountability
The Board is committed to provide shareholders with a clear assessment of the Group’s position and prospects. This is achieved through this report and as required other periodic financial and trading statements.
Going concern – As part of their going concern assessment set out in note 2.3, the Board of Directors have reviewed cash flow forecasts reviewed for the 12 months from the date these financial statements were signed and considered the medium term outlook through to December 2025 as described in the Viability Statement. The Directors have a reasonable expectation that the Group will be able to continue in operation and meet its liabilities as they fall due over the period to December 2025 provided further funding can be raised as required. Due to the requirement to raise additional funding, a material uncertainty with regard to going concern has been disclosed at note 2.3.
Risk is monitored and assessed by the Board as a whole and are responsible for ensuring that the financial performance of the Company is properly monitored and reported. This process includes reviews of annual and interim accounts, results announcements, internal control systems, procedures and accounting policies. Risk management is carried out by the Board of Directors. The Board identifies and evaluates financial risks, and the key risk factors for the Company are contained in the Financial Statements for the year ended 30 September 2023.
Internal controls – The Board of Directors reviews the effectiveness of the Company’s system of internal controls in line with the requirement of the Code. The internal control system is designed to manage the risk of failure to achieve its business objectives. This covers internal financial and operational controls, compliance and risk management. Key controls consist of segregation of duties, authorisation and approval policies and accounting controls such as monthly reconciliations. The Directors consider the Company has appropriate and effective internal controls in place for the year under review and up to the date of approval of the Annual Report and Financial Statements. The Directors acknowledge their responsibility for the Company’s system of internal controls and for reviewing its effectiveness. Risk is monitored, assessed and managed by the Board as a whole who are responsible for ensuring that the financial performance of the Company is properly monitored and reported. This process includes reviews of annual and interim accounts, results announcements, internal control systems, procedures and accounting policies. The finance function is outsourced to FIM Capital Limited and details of the duties performed are in a formal agreement. The Board confirms the need for an ongoing process for identification, evaluation and management of significant risks faced by the Company. The Directors carry out a risk assessment before signing up to any commitments.
The Audit Committee
The Audit Committee comprises of Cameron Pearce, chairman of the committee, and Alex Passmore and aims to meet at least twice a year and is responsible for ensuring that the Group’s financial performance is properly monitored, controlled and reported to the Board. During the year of review, the Audit Committee met twice. The Audit Committee is responsible for the scope and effectiveness of the external audit and compliance by the Group with statutory and other regulatory requirements. Given the size of the Group and the relative simplicity of the systems, the Board considers that there is no current requirement for an internal audit function. The procedures that have been established to provide internal financial control are considered appropriate for a Group of its size and include controls over expenditure, regular reconciliations and management accounts.
The Group has no internal audit function at present, as it is not considered necessary given the current size and operations of the entity. This will be kept under review as the nature of operations becomes more complex with the planned development of the project.
The Audit Committee monitors in discussion with the auditors:
· the integrity of the financial statements of the Group and significant financial reporting judgments contained in them, such as the assessment of impairment to the Group’s intangible assets.
· any formal announcements relating to the Group’s financial performance
· the Group’s internal financial controls and risk management systems
· the external auditor’s independence and objectivity and the effectiveness of the audit process, taking into consideration relevant UK professional and regulatory requirements.
The Directors are responsible for taking such steps as are reasonably available to them to safeguard the assets of the Company and to prevent and detect fraud and other irregularities.
External auditor’s independence
Since the last tender which was conducted in 2018, Crowe U.K LLP has acted as independent auditor for six years. Crowe U.K LLP has completed mandatory partner rotation this year in accordance with their firm’s policy. The Audit Committee have held discussions with the external auditors to confirm there are no non-audit services provided, and no other independence considerations they should be aware of.
Remuneration and Nominations Committee
A Remuneration and Nominations Committee was established during 2020 and is made up of the two non-executive directors. The Committee comprises Sam Quinn, chairman of the committee, and Alex Passmore. They are not considered to be independent directors. The Board considers the committee composition of two directors to be sufficient due to the size of the company at this time. The Remuneration and Nomination Committee meets at least annually and is responsible for setting the remuneration policy for all executive directors and the Company’s chairman, including any compensation payments; recommends and monitors the level and structure of remuneration for senior management; evaluates the board of directors and examines the skills and characteristics required of board candidates. During the year of review, the Remuneration and Nomination Committee met once.
Remuneration paid to Directors in the period under review is disclosed in the Directors’ Remuneration Report.
The Committee is dedicated to implementing a remuneration policy that promotes long-term incentives and aligns the interests of directors with those of shareholders. Share and option awards should be phased, contain performance milestones where appropriate and encourage long term participation.
The Committee considers in defining the remuneration policy that arrangements should be clear and transparent, should avoid undue complexity, and should be proportional to the services provided in delivering the Company’s strategy and purpose.
The Remuneration Committee to date has focused on share options and bonus payments as the main incentives for executives, given the stage of development of the Company and to further align senior management with shareholder interests. Typically share options are subject to vesting conditions, such as completion of feasibility studies or the introduction of strategic partners. In addition share price hurdles have been used to provide further shareholder alignment. Given the nature of the Company as the developer of a mining project and the potential for rerating of the Company’s value as the project advances, having a direct equity exposure is deemed to be the most desirable form of management incentive. In addition, cash bonus payments are generally kept to a minimum to preserve the Company’s capital. Share options will typically expire three months following the cessation of employment.
In accordance with the Company’s Articles of Association, at every annual general meeting at least one third of the current directors who are subject to retirement by rotation will be put forward to retire.
Shareholder relations
Communication and dialogue – Open and transparent communication with shareholders is given high priority and there is regular dialogue with institutional investors, as well as general presentations made at the time of the release of the annual and interim financial results. All Directors are kept aware of changes in major shareholdings in the Company and are available to meet with shareholders who have specific interests or concerns. The Company issues its results promptly to the market via RNS and also publishes them on the Company’s website: www.blencoweresourcesplc.com. Regular market news updates are made in relation to the Company including the status of its exploration and development programme which is also included on the Company’s website. Shareholders and other interested parties can subscribe to receive news updates by email by registering online on the website free of charge.
The Directors are available to meet with institutional shareholders to discuss any issues and gain an understanding of the Company’s business, its strategies and governance. Meetings are also held with the corporate governance representatives of institutional investors when requested.
Annual General Meeting – At every AGM individual shareholders are given the opportunity to put questions to the Chairman and to other members of the Board that may be present. Notice of the AGM is sent to shareholders at least 21 working days before the meeting. Details of proxy votes for and against each resolution, together with the votes withheld are announced to the London Stock Exchange and are published on the Company’s website as soon as practical after the meeting.
Viability statement
In accordance with provision 31 of the UK Corporate Governance Code (2018), the Board has assessed the prospects of the Group over a two-year period, taking account of the Group’s current position and principal risks. For information regarding Group’s going concern position and funding requirements over the next twelve months, please see note 2.3.
Time frame
The Board believes that two years is currently the most appropriate time frame over which the Board should assess the long-term viability of the Group. The Group’s current activities do not generate any revenues or positive operating cash flow, and the completion of the Definitive Feasibility Study for the Orom-Cross Graphite Project will require further capital expenditures.
Assessing viability
The main assumption in the Board making its viability assessment is the ability of the Group to raise further funds in order to progress from the exploration phase into feasibility and eventually into production of revenues. The Group may not be able to obtain additional financing as and when needed which could result in a delay or indefinite postponement of exploration and development activities.
Principal risk
The Directors have carried out a robust assessment of the principal risks facing the Group as described on the preceding pages including those that threaten its business model, future performance, solvency or liquidity. The Directors are confident that they have put in place a strong management team with wide-ranging expertise in mineral exploration and development who are capable of dealing with the risk management in order to safeguard the Group’s assets. The directors are aware that the risks that could have the most adverse effect are funding and capital markets, potential other risks include the political risk in the country of business.
Based on the financial impact of the analysis outlined above and the associated risks, management actions and controls that are either in place or could be implemented, the Board has been able to conclude that the Company will be able to deliver the Orom-Cross Graphite Project.
Confirmation of viability
Taking account of these matters, the Directors have a reasonable expectation that the Group will be able to continue in operation and meet its liabilities as they fall due over the period to December 2025, assuming that the financing referred to above is completed as described. The Company’s going concern statement is detailed in note 2.3.
By Order of the Board
Cameron Pearce
Director
30 January 2024
Statement of Blencowe Plc’s policy on Directors’ Remuneration
The Directors’ Remuneration Report sets out the Company’s policy on the remuneration of Directors together with the details of Directors’ remuneration packages and services contracts for the year ended 30 September 2023.
As set out in the Company’s Prospectus dated 30 March 2020, each of the Directors may be paid a fee at such rate as may from time to time be determined by the Board. All the Directors are entitled to be reimbursed by the Company for travel, hotel and other expenses incurred by them in the course of their directors’ duties relating to the Company.
Any fees payable to the Directors after an Acquisition will be determined as part of the negotiations for the Acquisition, and will be dependent on whether the Directors remain on the board of the Company in any event.
There have been no changes to the Directors’ remuneration or remuneration policy since the publication of the Company’s Prospectus dated 30 March 2020 with the exception of those mentioned below. The terms and conditions of appointment for all the members of the Board are available for inspection at our registered office.
Terms of employment
Cameron Pearce was appointed on 8 June 2018 by the Company to act as a Non-Executive Director and Chairman of the Company. Following the Company’s readmission to the London Stock Exchange (“LSE”) on 28 April 2020, Mr Pearce was reappointed with fees of £96,000 per annum. If there is a change of control (as defined in the letter of appointment), Mr Pearce will be entitled to 100% of his annual fee as a lump sum payment if the Company terminates his employment, or if Mr Pearce chooses to terminate his appointment within 12 months following a change of control.
Sam Quinn was appointed on 8 June 2018 by the Company to act as a Non-Executive Director, Following the readmission of the Company to the LSE on 28 April 2020, Mr Quinn was engaged as a Non-Executive director with fees of £24,000 per annum. If there is a change of control (as defined in the letter of appointment), Mr Quinn will be entitled to 100% of his annual fee as a lump sum payment if the Company terminates his employment, or if Mr Quinn chooses to terminate his appointment within 12 months following a change of control.
Alex Passmore was appointed on 8 June 2018 by the Company to act as a Non-Executive Director with fees of £12,000 per annum. On 15 March 2021, the Board agreed to increase Mr Passmore’s fees from 1 March 2021 to £18,000 per annum. If there is a change of control (as defined in the letter of appointment), Mr Passmore will be entitled to 100% of his annual fee as a lump sum payment if the Company terminates his employment, or if Mr Passmore chooses to terminate his appointment within 12 months following a change of control.
Remuneration Policy
Base salary levels will take into account market data for the relevant role, internal relativities, the individual’s experience and their current base salary. Where an individual is recruited below market norms, they may be re-aligned over time (e.g. two to three years), subject to performance in the role. Benefits will generally be in accordance with the approved policy. Currently, there are no benefits in place.
The Remuneration and Nomination Committee comprises Sam Quinn, who acts as chairman of the committee and Alex Passmore, and meets at least annually. The Remuneration Committee reviews the scale and structure of the Directors’ fees, considering the interests of the shareholders and the performance of the Company and Directors. Bonuses, pay rises and the grant of long term incentives such as share options are linked to the achievement of key funding and project milestones that are set from time to time by the Committee.
The items included in this report are unaudited unless otherwise stated.
The Company maintains contact with its shareholders about remuneration in the same way as other matters and, as required by Section 439 of the Companies Act 2006, this remuneration report will be put to an advisory vote of the Company’s shareholders at the forthcoming Annual General Meeting
Directors’ emoluments and compensation (audited)
Set out below are the emoluments of the Directors:
|
Cameron Pearce |
Sam Quinn |
Alexander Passmore |
Total |
|
|
|
|
|
30 September 2022 |
|
|
|
|
Base fee |
96,000 |
24,000 |
18,000 |
138,000 |
Bonuses |
16,000 |
4,000 |
3,000 |
23,000 |
Share Based Payments |
21,068 |
14,045 |
7,023 |
42,136 |
Total 30 September 2022 |
133,068 |
42,045 |
28,023 |
203,136 |
|
|
|
|
|
30 September 2023 |
|
|
|
|
Base fee |
96,000 |
24,000 |
18,000 |
138,000 |
Share based payments |
5,239 |
5,239 |
2,619 |
13,097 |
Total 30 September 2023 |
101,239 |
29,239 |
20,619 |
151,097 |
The percentage of directors’ emoluments of the total administrative costs for the year is 12% (2022: 30%). The directors’ base fees increased did not increase (2022: Nil) while the base salary costs of the key management employees did not increase (2022: 28%).
Statement of Directors’ shareholding and share interest (audited)
The Directors who served during the year ended 30 September 2023, and their interests at that date, are disclosed on page 11.
Issue of options
As at the reporting date, the number of shares options that the Company has issued to the Board and Senior Management are as follow;
Cameron Pearce (Chairman) |
5,000,000 |
|
Mike Ralston (CEO) |
5,500,000 |
|
Lionshead Consultants Ltd (Sam Quinn) (Non Exec Director) |
3,750,000 |
|
Alexander Passmore (Non Exec Director) |
1,750,000 |
|
Iain Wearing (COO) |
5,000,000 |
|
For further information, please see notes 17 and 20.
Other matters
The Company does not currently have any annual or long-term incentive schemes (other than the one stated above) in place for any of the Directors and as such there are no disclosures in this respect.
The Company does not have any pension plans for any of the Directors and does not pay pension amounts in relation to their remuneration.
The Company has not paid out any excess retirement benefits to any Directors or past Directors. The Company has not paid any compensation to past Directors.
By Order of the Board
Sam Quinn
Director
30 January 2024
Independent Auditor’s Report to the Members of Blencowe Resources Plc
Opinion
We have audited the financial statements of Blencowe Resources Plc (the “Parent Company”) and its subsidiary (the ‘Group’) for the year ended 30 September 2023 which comprise the Consolidated statement of comprehensive income, Consolidated statement of financial position, Parent Company statement of financial position, Consolidated statement of changes in equity, Parent Company statement of changes in equity, Consolidated statement of cash flows, Parent Company statement of cash flows and notes to the financial statements, including significant accounting policies. The financial reporting framework that has been applied in the preparation of the Group and the Parent Company financial statements is applicable law and UK-adopted international accounting standards.
In our opinion:
· the financial statements give a true and fair view of the state of the Group’s and of the Parent Company’s affairs as at 30 September 2023 and of the Group’s loss for the year then ended;
· the Group and the Parent Company financial statements have been properly prepared in accordance with UK-adopted international accounting standards: and
· the financial statements have been prepared in accordance with the requirements of the Companies Act 2006.
Basis for opinion
We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditor’s responsibilities for the audit of the financial statements section of our report. We are independent of the Group and the Parent Company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC’s Ethical Standard as applied to listed public interest entities, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.
Material uncertainty in relation to going concern
We draw attention to note 2.3 to the financial statements, which explains that the Group and Parent Company’s ability to continue as a going concern is dependent on the availability on further fundraising. These conditions indicate the existence of a material uncertainty which may cast significant doubt over the Group’s and Parent Company’s ability to continue as a going concern. Our opinion is not modified in respect of this matter.
In auditing the financial statements, we have concluded that the directors’ use of the going concern basis of accounting in the preparation of the financial statements is appropriate. We have highlighted going concern as a key audit matter due to the estimates and judgements the Directors are required to make in their going concern assessment, and their effect on our audit strategy. Our audit work in response to this key audit matter included:
· We obtained the going concern assessment prepared by the directors, and performed a detailed review of the supporting cash flow forecasts. We challenged the key assumptions based on expected activity within the going concern period, and comparison to historical actual monthly expenditure.
· We checked the mathematical accuracy of the projections and agreed the opening cash position to bank statements. We confirmed that the period of going concern assessment covered at least twelve months from the date of approval of the financial statements, and enquired regarding any matters shortly after this date that would impact the going concern consideration.
· We reviewed the prior year going concern projections against the actual performance in the current financial year, in order to assess management’s ability to forecast accurately.
· We assessed the systems and controls in place for the preparation of management’s going concern projections.
· We reviewed the requirements of the grant awarded by the US Development Funding Council in September 2023 regarding works to be performed in order to receive each tranche of funding. We discussed with the directors how these were factored into budgets and exploration plans during the going concern assessment period.
· We held discussions with the directors on how they plan to raise the additional funding required by the cash flow forecasts. This was considered against their previous success in fundraising for the project.
· We reviewed the completeness of disclosures made in the financial statements in relation to going concern, and that these are in line with the going concern assessment provided to us by the directors.
Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.
Overview of our audit approach
Materiality
In planning and performing our audit we applied the concept of materiality. An item is considered material if it could reasonably be expected to change the economic decisions of a user of the financial statements. We used the concept of materiality to both focus our testing and to evaluate the impact of misstatements identified.
Based on our professional judgement, we determined overall materiality for the financial statements as a whole to be £155,000 (2022 £140,000), based on 2% of total assets. Materiality for the parent company financial statements as a whole was set at £140,000 (2022: £120,000) based on 2% of total assets.
We use a different level of materiality (‘performance materiality’) to determine the extent of our testing for the audit of the financial statements. Performance materiality is set based on the audit materiality as adjusted for the judgements made as to the entity risk and our evaluation of the specific risk of each audit area having regard to the internal control environment. Performance materiality was set at 70% of materiality for the financial statements as a whole, which equates to £108,500 (2022: £98,000) for the Group and £98,000 (2022: £84,000) for the parent.
Where considered appropriate performance materiality may be reduced to a lower level, such as, for related party transactions and directors’ remuneration.
We agreed with the Audit Committee to report to it all identified errors in excess of £7,700 (2022: £7,000). Errors below that threshold would also be reported to it if, in our opinion as auditor, disclosure was required on qualitative grounds.
Overview of the scope of our audit
Our Group audit was scoped by obtaining an understanding of the Group and its environment, including the Group’s system of internal control, and assessing the risks of material misstatement in the financial statements. We also addressed the risk of management override of internal controls, including assessing whether there was evidence of bias by the Directors that may have represented a risk of material misstatement.
The Group operates through the Parent Company based in the United Kingdom whose main function is the incurring of administrative costs and providing funding to its exploration subsidiary in Uganda. The Parent Company, and its Ugandan subsidiary, were both considered to be a significant components.
In establishing our overall approach to the group audit, we determined the type of work that needed to be performed in respect of each component. As significant components, full scope audit were performed for both the Parent Company and the Ugandan subsidiary. All audit work was carried out by the group audit team.
Given the Ugandan subsidiary is in the exploration stage of its work, we did not consider it necessary to visit Uganda. Documentation and explanations from Uganda were obtained by email and through telephone calls.
Key Audit Matters
Key audit matters are those matters that, in our professional judgment, were of most significance in our audit of the financial statements of the current period and include the most significant assessed risks of material misstatement (whether or not due to fraud) we identified, including those which had the greatest effect on the overall audit strategy, the allocation of resources in the audit; and directing the efforts of the engagement team. These matters were addressed in the context of our audit of the financial statements as a whole, and in forming our opinion thereon, and we do not provide a separate opinion on these matters.
We set out below, together with the material uncertainty in relation to going concern above, those matters we considered to be key audit matters.
Key audit matter |
How our scope addressed the key audit matter |
1. Carrying value of intangible assets (note 9) The Group carries intangible assets totalling £7.6m (2022: £6.6m) in relation to the Orom-Cross project in Uganda. These costs are capitalised in accordance with the requirements of IFRS 6. At each reporting date, the directors are required to assess whether there are any indicators of impairment, that would require an impairment assessment to be carried out. The directors concluded there were no indicators of impairment. The directors’ consideration of the impairment indicators requires them to make certain judgements, and may include certain estimates. These matters, together with the materiality of the exploration and evaluation assets make this a key audit matter.
|
We performed the following procedures as part of our audit of management’s assessment of the carrying value of intangible assets: · We obtained and reviewed the directors’ assessment of the indicators of impairment, as set out in IFRS 6 “Exploration for and evaluation of mineral resources”. · We assessed the design and implementation of controls over the impairment assessment process. · We obtained copies of all licenses held by the Group, and performed procedures to confirm the Group’s control of the licenses, that they remain valid, and to check there is an expectation that any exploration licenses that have expired will be renewed in the normal course of business. · We made specific enquiries of the directors and key staff involved in the exploration work, and reviewed budgets and forecasts to support the Group continuing with further exploration work in each of its license areas. · We considered the results of the bulk sampling works completed during the period, for any matters that may indicate impairment. · We reviewed the adequacy of disclosures in the financial statements in relation to the impairment consideration. Based on our work performed, we consider the directors’ assessment, and the financial statements disclosures to be appropriate. |
Our audit procedures in relation to these matters were designed in the context of our audit opinion as a whole. They were not designed to enable us to express an opinion on these matters individually and we express no such opinion.
Other information
The other information comprises the information included in the annual report other than the financial statements and our auditor’s report thereon. The directors are responsible for the other information contained within the annual report.
Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon. Our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the course of the audit, or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.
We have nothing to report in this regard.
Opinions on other matters prescribed by the Companies Act 2006
In our opinion the part of the directors’ remuneration report to be audited has been properly prepared in accordance with the Companies Act 2006.
In our opinion based on the work undertaken in the course of our audit:
· the information given in the strategic report and the directors’ report for the financial year for which the financial statements are prepared is consistent with the financial statements; and
· the directors’ report and strategic report have been prepared in accordance with applicable legal requirements.
Matters on which we are required to report by exception
In the light of the knowledge and understanding of the Group and the Parent Company and their environment obtained in the course of the audit, we have not identified material misstatements in the strategic report or the directors’ report.
We have nothing to report in respect of the following matters in relation to which the Companies Act 2006 requires us to report to you if, in our opinion:
· adequate accounting records have not been kept by the company, or returns adequate for our audit have not been received from branches not visited by us; or
· the company financial statements and the part of the directors’ remuneration report to be audited are not in agreement with the accounting records and returns; or
· certain disclosures of directors’ remuneration specified by law are not made; or
· we have not received all the information and explanations we require for our audit
Corporate governance statement
We have reviewed the directors’ statement in relation to going concern, longer-term viability and that part of the Corporate Governance Statement relating to the entity’s voluntary compliance with the provisions of the UK Corporate Governance Statement specified for our review.
Based on the work undertaken as part of our audit, we have concluded that each of the following elements of the Corporate Governance Statement is materially consistent with the financial statements and our knowledge obtained during the audit:
· Directors’ statement with regards the appropriateness of adopting the going concern basis of accounting and any material uncertainties identified set out on page 17;
· Directors’ explanation as to their assessment of the Group’s prospects, the period this assessment covers and why they period is appropriate set out on pages 19 and 20.
· Directors’ statement on whether they have a reasonable expectation that the Group will be able to continue in operation and meets its liabilities set out on page 17;
· Directors’ statement on fair, balanced and understandable set out on page 13;
· Board’s confirmation that it has carried out a robust assessment of the emerging and principal risks set out on page 5;
· Section of the annual report that describes the review of effectiveness of risk management and internal control systems set out on page 17; and
· Section describing the work of the audit committee set out on page 18.
Responsibilities of the directors for the financial statements
As explained more fully in the directors’ responsibilities statement set out on page 13, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.
In preparing the financial statements, the directors are responsible for assessing the Group’s and the Parent Company’s ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the Group or the Parent Company or to cease operations, or have no realistic alternative but to do so.
Auditor’s responsibilities for the audit of the financial statements
Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor’s report that includes our opinion. Reasonable assurance is a high level of assurance but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.
Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our responsibilities, outlined above, to detect material misstatements in respect of irregularities, including fraud. The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below:
· We obtained an understanding of the legal and regulatory frameworks that are applicable to the Group, and the procedures in place for ensuring compliance. The most significant regulations identified were the Companies Act 2006, listing rules of the London Stock Exchange and the requirements of the Group’s mining and exploration licenses. Our work included direct enquiry of the directors, who oversee all legal proceedings, reviewing Board minutes and inspection of correspondence.
· We made enquiries of management, the Audit Committee and the Group’s external legal counsel in Uganda about any litigations and claims and compliance with local legislation in Uganda.
· We communicated the relevant laws and regulations identified to all members of the engagement team, and remained alert to any indication of non-compliance with laws and regulations, or potential fraud, throughout our audit work.
· As part of our audit planning process we assessed the different areas of the financial statements, including disclosures, for the risk of material misstatement. This included considering the risk of fraud where direct enquiries were made of management and those charged with governance concerning both whether they had any knowledge of actual or suspected fraud and their assessment of the susceptibility of fraud. We considered the risk was greater in areas that involve significant management estimate or judgement. Based on this assessment we designed audit procedures to focus on the key areas of estimation or judgement, this included risk-based testing of journal transactions using data analytic software, both at the year end and throughout the year.
Owing to the inherent limitations of an audit, there is an unavoidable risk that some material misstatements of the financial statements may not be detected, even though the audit is properly planned and performed in accordance with the ISAs (UK). The potential effects of inherent limitations are particularly significant in the case of misstatement resulting from fraud because fraud may involve sophisticated and carefully organized schemes designed to conceal it, including deliberate failure to record transactions, collusion or intentional misrepresentations being made to us.
A further description of our responsibilities for the audit of the financial statements is located on the Financial Reporting Council’s website at: www.frc.org.uk/auditorsresponsibilities. This description forms part of our auditor’s report.
Other matters which we are required to address
We were appointed by the board of Directors on 14 December 2018 to audit the financial statements for the period ending 30 September 2018. Our total uninterrupted period of engagement is six years, covering the periods ending 30 September 2018 to 30 September 2023.
The non-audit services prohibited by the FRC’s Ethical Standard were not provided to the Group or the Parent Company and we remain independent of the Group and the Parent Company in conducting our audit.
Our audit opinion is consistent with the additional report to the audit committee.
Use of our report
This report is made solely to the Parent Company’s members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the Parent Company’s members those matters we are required to state to them in an auditor’s report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the Parent Company and the Parent Company’s members as a body, for our audit work, for this report, or for the opinions we have formed.
Nick Jones
Senior Statutory Auditor
For and on behalf of
Crowe U.K. LLP
Statutory Auditor
London, U.K.
Consolidated Statement of Comprehensive Income
for the year ended 30 September 2023
Notes |
30 Sep 2023 |
30 Sep 2022 |
|
GBP |
GBP |
||
|
|
||
Exploration costs |
(53,347) |
(4,853) |
|
Impairment – Akelikongo project |
9 |
– |
(404,533) |
Administrative fees and other expenses |
5 |
(1,298,872) |
(681,488) |
Adjustments to surface liability |
15 |
– |
51,316 |
Operating loss |
|
(1,352,219) |
(1,039,558) |
|
|
|
|
Finance costs |
15 |
(45,748) |
(45,916) |
Loss before tax |
|
(1,397,967) |
(1,085,474) |
|
|
|
|
Taxation |
8 |
– |
– |
|
|
|
|
Loss for the year attributable to owners of the parent |
|
(1,397,967) |
(1,085,474) |
|
|
|
|
Other comprehensive income |
|
|
|
Items that may be reclassified to profit or loss: |
|
|
|
Exchange differences on translation of foreign operation: |
|
31,282 |
(4,205) |
Other comprehensive income/(loss), net of tax |
|
31,282 |
(4,205) |
|
|
|
|
Total comprehensive loss attributable to owners of the parent |
|
(1,366,685) |
(1,089,679) |
|
|
|
|
Basic and diluted loss per share (pence) |
10 |
(0.70) |
(0.68) |
Consolidated Statement of Financial Position as at 30 September 2023
Notes |
30 Sep 2023 |
30 Sep 2022 |
|
GBP |
GBP |
||
|
|||
Non-Current Assets |
|
||
Intangible assets |
9 |
7,604,564 |
6,615,253 |
|
|||
Current assets |
|
||
Trade and other receivables |
13 |
31,863 |
85,847 |
Cash and cash equivalents |
129,853 |
346,994 |
|
Total current assets |
161,716 |
432,841 |
|
|
|||
Total assets |
7,766,280 |
7,048,094 |
|
|
|||
Current liabilities |
|
||
Creditors: Amounts falling due within one year |
14 |
(1,076,169) |
(326,375) |
Total current liabilities |
(1,076,169) |
(326,375) |
|
|
|||
Non-current liabilities |
|
||
Surface liabilities |
15 |
(818,915) |
(823,852) |
|
|||
Total liabilities |
|
(1,895,084) |
(1,150,227) |
|
|||
Net assets |
5,871,196 |
5,897,867 |
|
|
|||
Equity |
|
||
Share capital |
16 |
1,338,566 |
1,181,316 |
Share premium |
16 |
8,637,399 |
7,480,829 |
Share options reserve |
428,342 |
402,148 |
|
Translation reserve |
2.9 |
30,739 |
(543) |
Accumulated losses |
(4,563,850) |
(3,165,883) |
|
Total equity |
|
5,871,196 |
5,897,867 |
These financial statements were approved by the Board of Directors and authorised for issue on 30 January 2024 and signed on its behalf by:
Cameron Pearce Sam Quinn
Director Director
Parent Statement of Financial Position as at 30 September 2023
|
|
||
Notes |
30 Sep 23 |
30 Sep 22 |
|
|
GBP |
GBP |
|
|
|||
Fixed assets |
|
||
Investment in subsidiaries |
11 |
6,027,940 |
4,892,924 |
Non-current assets |
12 |
671,905 |
521,944 |
Total fixed assets |
|
6,699,845 |
5,414,868 |
|
|||
Current assets |
|
||
Trade and other receivables |
13 |
342,197 |
315,030 |
Cash and cash equivalents |
129,853 |
346,994 |
|
Total current assets |
472,050 |
662,024 |
|
|
|||
Total assets |
|
7,171,895 |
6,076,892 |
|
|||
Current liabilities |
|
||
Creditors: Amounts falling due within one year |
14 |
(567,867) |
(159,530) |
Total current liabilities |
|
(567,867) |
(159,530) |
|
|
||
Net assets |
6,604,028 |
5,917,362 |
|
|
|||
Equity |
|
||
Share capital |
16 |
1,338,566 |
1,181,316 |
Share premium |
16 |
8,637,399 |
7,480,829 |
Share options reserve |
428,342 |
402,148 |
|
Accumulated losses |
(3,800,279) |
(3,146,931) |
|
Total equity |
|
6,604,028 |
5,917,362 |
|
The Company has taken advantage of the exemption allowed under section 408 of the Companies Act 2006 and has not presented its own Statement of Comprehensive Income in these financial statements. The loss after tax of the parent Company for the year was £653,348 (2022: £1,178,756).
The Financial Statements were approved and authorised for issue by the Board of Directors on 30 January 2024 and were signed on its behalf by:
Cameron Pearce Sam Quinn
Director Director
Consolidated Statement of Changes in Equity for the year ended 30 September 2023
|
Share capital |
Share premium |
Share option reserve |
Accumulated losses |
Translation reserve |
Total equity |
GBP |
GBP |
GBP |
GBP |
GBP |
GBP |
|
Balance as at 30 Sep 2021 |
901,316 |
5,132,081 |
317,876 |
(2,080,409) |
3,662 |
4,274,526 |
Loss for the year |
– |
– |
– |
(1,085,474) |
– |
(1,085,474) |
Exchange differences on translation of foreign operations |
– |
– |
– |
– |
(4,205) |
(4,205) |
Total comprehensive loss |
– |
– |
– |
(1,085,474) |
(4,205) |
(1,089,679) |
Transactions with owners |
|
|
|
|
|
|
New shares issued (note 16) |
280,000 |
2,520,000 |
– |
– |
– |
2,800,000 |
Share issue costs |
– |
(171,252) |
– |
– |
– |
(171,252) |
Share based payment charge |
– |
– |
84,272 |
– |
– |
84,272 |
Total transactions with owners |
280,000 |
2,348,748 |
84,272 |
– |
– |
2,713,020 |
Balance as at 30 Sep 2022 |
1,181,316 |
7,480,829 |
402,148 |
(3,165,883) |
(543) |
5,897,867 |
|
|
|
|
|
|
|
Loss for the year |
– |
– |
– |
(1,397,967) |
– |
(1,397,967) |
Exchange differences on translation of foreign operations |
– |
– |
– |
– |
31,282 |
31,282 |
Total comprehensive loss |
– |
– |
– |
(1,397,967) |
31,282 |
(1,366,685) |
|
|
|
|
|
|
|
Transactions with owners |
|
|
|
|
|
|
New shares issued (note 16) |
157,250 |
1,227,750 |
– |
– |
– |
1,385,000 |
Share issue costs |
– |
(71,180) |
– |
– |
– |
(71,180) |
Share based payment charge |
– |
26,194 |
– |
– |
26,194 |
|
Total transactions with owners |
157,250 |
1,156,570 |
26,194 |
– |
– |
1,340,014 |
|
|
|
|
|
|
|
Balance as at 30 Sep 2023 |
1,338,566 |
8,637,399 |
428,342 |
(4,563,850) |
30,739 |
5,871,196 |
Parent Statement of Changes in Equity for the year ended 30 September 2023
|
Share capital |
Share premium |
Share option reserve |
Accumulated losses |
Total equity |
GBP |
GBP |
GBP |
GBP |
GBP |
|
Balance as at 30 Sep 2021 |
901,316 |
5,132,081 |
317,876 |
(1,968,175) |
4,383,098 |
Loss for the year |
– |
– |
– |
(1,178,756) |
(1,178,756) |
Total comprehensive loss |
– |
– |
– |
(1,178,756) |
(1,178,756) |
|
|
|
|
|
|
Total transactions with owners |
|||||
New shares issued (note 16) |
280,000 |
2,520,000 |
– |
– |
2,800,000 |
Share issue costs |
– |
(171,252) |
– |
– |
(171,252) |
Share based payment charge |
– |
– |
84,272 |
– |
84,272 |
Total transactions with owners |
280,000 |
2,348,748 |
84,272 |
– |
2,713,020 |
Balance as at 30 Sep 2022 |
1,181,316 |
7,480,829 |
402,148 |
(3,146,931) |
5,917,362 |
|
|
|
|
|
|
Loss for the year |
– |
– |
– |
(653,348) |
(653,348) |
Total comprehensive loss |
– |
– |
– |
(653,348) |
(653,348) |
|
|
|
|
|
|
Total transactions with owners |
|
|
|
|
|
New shares issued (note 16) |
157,250 |
1,227,750 |
– |
– |
1,385,000 |
Share issues costs |
– |
(71,180) |
– |
– |
(71,180) |
Share based payment charge |
– |
– |
26,194 |
– |
26,194 |
|
|
|
|
|
|
Total transactions with owners |
157,250 |
1,156,570 |
26,194 |
– |
1,340,014 |
|
|
|
|
|
|
Balance as at 30 Sep 2023 |
1,338,566 |
8,637,399 |
428,342 |
(3,800,279) |
6,604,028 |
Consolidated Statement of Cash Flows for the year ended 30 September 2023
Notes |
30 Sep 2023 |
30 Sep 2022 |
|
GBP |
GBP |
||
Operating activities |
|
|
|
Loss after tax |
(1,397,967) |
(1,085,474) |
|
Finance costs |
45,748 |
45,916 |
|
Adjustment to surface liability |
15 |
– |
(51,316) |
Share based payment |
17 |
26,194 |
84,272 |
Impairment – Akelikongo costs |
9 |
– |
404,533 |
Unrealised currency translation |
182,264 |
(208,371) |
|
Changes in working capital |
|||
Decrease/(increase) in trade and other receivables |
53,984 |
(33,267) |
|
Increase in trade and other payables |
272,664 |
76,483 |
|
Net cash flows utilised by operating activities |
(817,113) |
(767,224) |
|
Cash flows from investing activities |
|||
Investment in exploration assets |
9 |
(713,848) |
(1,423,236) |
Net cash flows utilised by investing activities |
|
(713,848) |
(1,423,236) |
Cash flows from financing activities |
|
||
Shares issued (net of issue cost) |
16 |
1,313,820 |
2,444,166 |
Net cash flows from financing activities |
1,313,820 |
2,444,166 |
|
(Decrease)/increase in cash and cash equivalents |
(217,141) |
253,706 |
|
Cash and cash equivalents at the beginning of the year |
346,994 |
93,288 |
|
Cash and cash equivalents at the end of the year |
|
129,853 |
346,994 |
Net Debt note
|
Cash at bank and in hand |
Surface Liability |
Total |
|
GBP |
GBP |
GBP |
At 1 October 2021 |
93,288 |
(887,560) |
(794,272) |
Cash flows |
253,706 |
– |
253,706 |
Other non-cash changes |
– |
(90,695) |
(90,695) |
As 30 September 2022 |
346,994 |
(978,255) |
(631,261) |
|
|
|
|
As 30 September 2022 |
346,994 |
(978,255) |
(631,261) |
Cash flows |
(217,141) |
– |
(217,141) |
Other non-cash changes |
– |
159,340 |
159,340 |
As 30 September 2023 |
129,853 |
(818,915) |
(689,062) |
Parent Statement of Cash Flows for the year ended 30 September 2023
30 Sep 2023 |
30 Sep 2022 |
||
|
|
||
Notes |
GBP |
GBP |
|
Operating activities |
|
|
|
Loss after tax |
(653,348) |
(1,178,756) |
|
Less finance income |
(55,873) |
(24,354) |
|
Increase in bad debt provision |
12,13 |
11,742 |
9,408 |
Share based payment |
17 |
26,194 |
84,272 |
Changes in working capital |
|||
Increase in trade and other receivables |
(27,167) |
(120,783) |
|
(Decrease)/increase in trade and other payables |
(58,641) |
64,002 |
|
Net cash flows from operating activities |
(757,093) |
(1,166,211) |
|
Cash flows from investing activities |
|||
Loan advanced to subsidiary |
(105,828) |
(68,278) |
|
Investment in subsidiary, relating to exploration costs paid |
11 |
(668,040) |
(955,971) |
Net cash flows from investing activities |
(773,868) |
(1,024,249) |
|
|
|
|
|
Cash flows from financing activities |
|
||
Shares issued (net of issue cost) |
16 |
1,313,820 |
2,444,166 |
Net cash flows from financing activities |
1,313,820 |
2,444,166 |
|
Increase/(decrease) in cash and cash equivalents |
(217,141) |
253,706 |
|
Cash and cash equivalents at the beginning of the year |
346,994 |
93,288 |
|
Cash and cash equivalents at the end of the year |
|
129,853 |
346,994 |
1. General
Blencowe Resources Plc (the “Company”) is a public limited company incorporated and registered in England and Wales on 18 September 2017 with registered company number 10966847 and its registered office is situated in England and Wales at 167-169 Great Portland Street, Fifth Floor London, W1W 5PF.
The Group did not earn any trading income during the year under review but incurred expenditure associated with financing and operation of the Group and developing its principal assets.
2. Accounting Policies
2.1 Basis of preparation
The principal accounting policies applied in the preparation of the Company and Group’s Financial Statements are set out below. These policies have been consistently applied to the periods presented, unless otherwise stated.
The Company and Group’s Financial Statements have been prepared in accordance with UK adopted international accounting standards (“IFRS”). The Company Financial Statements have been prepared using the measurement bases specified by IFRS for each type of asset, liability, income and expense.
The Group’s Financial Statements are presented in GBP, which is the Company’s functional currency. All amounts have been rounded to the nearest pound, unless otherwise stated.
2.2 Basis of consolidation
The Consolidated Financial Statements comprise the financial statements of the Company and its subsidiary Consolidated African Resources Limited (“CARU”) ) (formerly Blencowe Resources Uganda Ltd (“BRUL”).
Subsidiaries are fully consolidated from the date of acquisition, being the date on which the Group obtains control. Control is achieved when the Group is exposed, or has rights, to variable returns from its involvement with the investee and has the ability to affect those returns through its power over an investee, including:
• the contractual arrangement with the other vote holders of the investee;
• rights arising from other contractual arrangements; and
• the Group’s voting rights and potential voting rights
The Group re-assesses whether or not it controls an investee if facts and circumstances indicate that there are changes to one or more of the three elements of control. Subsidiaries are fully consolidated from the date on which control is transferred to the Group. They are deconsolidated from the date that control ceases. Assets, liabilities, income and expenses of a subsidiary acquired or disposed of during the period are included in the Group Financial Statements from the date the Group gains control until the date the Group ceases to control the subsidiary.
All intra-group balances, transactions, income and expenses and profits and losses resulting from intra-group transactions that are recognised, are eliminated in full.
2.3 Going concern
At 30 September 2023, the Group had £7,766,280 of total assets (2022: £7,048,094), of which £129,853 are held as cash and cash equivalents (2022: £346,994).
In making an assessment of going concern for the Group and Company, the Board of Directors have reviewed cash flow forecasts covering a period of 12 months from the date these financial statements were approved, and have concluded that it is appropriate to prepare the financial statements on a going concern basis.
The Group has successfully been granted a $5 million grant through the US Development Finance Corporation (DFC). This funding will be provided in a number of tranches aligned to completion of works related to the Definitive Feasibility Study. The DFC grant will not cover the entirety of the DFS costs and hence additional funding will be required during the going concern period. These conditions are considered to indicate the existence of a material uncertainty, which may cast doubt over the Group’s and Company’s ability to continue as a going concern. The financial statements do not include adjustments that would arise in the event of the Group and Company not being a going concern.
2.4 Changes in significant accounting policies
The Group has adopted all new IFRS and amendments to IFRS applicable for this period. There has been no change to the Group’s accounting policies as a result, and no other significant impact to the financial statements.
2.5 Standards, amendments and interpretations to published standards not yet effective
The Directors have reviewed the IFRS standards in issue which are effective for annual accounting years ending on or after the stated effective date. In their view, none of these standards would have a material impact on the financial statements of the Group.
2.6 Intangible assets
Exploration and evaluation assets
The Group recognises expenditure as exploration and evaluation assets when it determines that those assets will be successful in finding specific mineral resources. Expenditure included in the initial measurements of exploration and evaluation assets and which are classified as intangible assets relate to the acquisition of rights to explore, exploratory drilling, sampling and activities to evaluate the technical feasibility and commercial viability of extracting a mineral resource. Capitalisation of pre-production expenditure ceases when the mining property is capable of commercial production.
Impairment
Exploration and evaluation assets are not subject to amortisation until production commences but are assessed for impairment when an event or trigger requires an assessment to be carried out. The assessment is carried out by allocating exploration and evaluation assets to cash generating units (“CGU’s”), which are based on specific projects or geographical areas. Currently there is only one CGU relating to the Orom-Cross Project. Whenever the exploration for and evaluation of mineral resources in cash generating units does not lead to the discovery of commercially viable quantities of mineral resources and the Group has decided to discontinue such activities of that unit, the associated expenditures are written off to the Statement of Comprehensive Income.
Exploration and evaluation assets recorded at fair-value on acquisition
Exploration assets which are acquired are recognised at fair value. When an entity is acquired whose only significant assets are its exploration asset and/or rights to explore, the Directors consider that the fair value of the exploration assets is equal to the consideration.
2.7 Financial instruments
A financial instrument is any contract that gives rise to a financial asset of one entity and a financial liability or equity instrument of another.
(i) Financial assets
Financial assets are classified at initial recognition. The classification of financial assets at initial recognition that are debt instruments depends on the financial asset’s contractual cash flow characteristics and the Group’s business model for managing them. The Group initially measures a financial asset at its fair value plus, in the case of a financial asset not at fair value through profit or loss, transaction costs.
In order for a financial asset to be classified and measured at amortised cost, it needs to give rise to cash flows that are ‘solely payments of principal and interest (SPPI)’ on the principal amount outstanding. This assessment is referred to as the SPPI test and is performed at an instrument level.
Classification and measurement is based on both whether contractual cash flows are solely payments of principal and interest; and whether the debt instrument is held to collect those cash flows. In the case of the Group, all financial assets meet this criteria and they are held at amortised cost.
Impairment of financial assets
IFRS 9’s impairment requirements use more forward-looking information to recognise expected credit losses – the ECL model.
ECLs are based on the difference between the contractual cash flows due in accordance with the contract and all the cash flows that the Company expects to receive, discounted at the original effective interest rate. The expected cash flows will include cash flows from the sale of collateral held or other credit enhancements that are integral to the contractual terms.
ECLs are recognised in two stages. For credit exposures for which there has not been a significant increase in credit risk since initial recognition, ECLs are provided for credit losses that result from default events that are possible within the next 12 months (a ’12-month ECL’). For those credit exposures for which there has been a significant increase in credit risk since initial recognition, a loss allowance is required for credit losses expected over the remaining life of the exposure, irrespective of the timing of the default (a ‘lifetime ECL’).
For the Company’s receivables from its subsidiary, management have assessed there to be no significant change in credit risk and have assessed a 12 month ECL at 5% to be appropriate for the current year. Therefore, the Company does not track changes in credit risk, but instead recognises a loss allowance based on lifetime ECLs at each reporting date.
(ii) Financial liabilities
Financial liabilities are classified, at initial recognition, as financial liabilities at amortised cost. The Group’s financial liabilities include trade and other payables and surface liabilities.
Subsequent measurements
Surface liabilities and trade and other payables.
After initial recognition, surface liabilities and trade and other payables are subsequently measured at amortised cost using the effective interest rate method. Gains and losses are recognised in the statement of profit or loss when the liabilities are derecognised, as well as through the effective interest rate amortisation process.
Amortised cost is calculated by taking into account any discount or premium on acquisition and fees or costs that are an integral part of the effective interest rate. The effective interest rate amortisation is included as finance costs in the statement of profit or loss.
Derecognition
A financial liability is derecognised when the associated obligation is discharged or cancelled or expires.
When an existing financial liability is replaced by another from the same lender on substantially different terms, or the terms of an existing liability are substantially modified, such an exchange or modification is treated as the derecognition of the original liability and the recognition of a new liability. The difference in the respective carrying amounts is recognised in profit or loss.
2.8 Share capital
Ordinary shares are classified as equity. Incremental costs directly attributable to the issue of new shares or options are shown in equity as a deduction, net of tax, from proceeds.
Warrants
Warrant options are classified as equity. The fair value of the warrants has been calculated using the Black-Scholes option pricing model. For more information, please see note 17.
Share options
The Group accounts for the equity-settled share options it has issued in accordance with IFRS 2. The share options are recognised at their fair value at the date of grant. The total share based payment charge expensed is recognised over the vesting period, which is the period over which performance conditions are to be satisfied. The fair value is calculated using the Black-Scholes option pricing model, adjusted for the probability of meeting market based vesting conditions where these are included. The inputs used in the model are based on management’s best estimate.
No expense is recognised for options that do not ultimately vest, except for awards where vesting is conditional on a market condition or non-vesting condition, which are treated as vesting irrespective of whether or not the market or non-vesting condition is satisfied, provided all other performance or service conditions are satisfied.
2.9 Foreign currency translation
(i) Functional and presentation currency
Items included in the financial statements of each of the group’s entities are measured using the currency of the primary economic environment in which the entity operates (‘the functional currency’). The consolidated financial statements are presented in Great British Pounds currency (GBP).
(ii) Transactions and balances
Foreign currency transactions are translated into the functional currency using the exchange rates at the dates of the transactions. Monetary assets and liabilities denominated in foreign currencies at the reporting date are retranslated to the functional currency at the exchange rate at that date. Foreign exchange gains and losses resulting from the settlement of such transactions, and from the translation of monetary assets and liabilities denominated in foreign currencies at year end exchange rates, are generally recognised in profit or loss.
Non-monetary assets and liabilities denominated in foreign currencies that are measured at fair value are retranslated to the functional currency at the exchange rate at the date that the fair value was determined. Non-monetary items in a foreign currency that are measured in terms of historical cost are translated using the exchange rate at the date of the transaction. Foreign currency differences arising on the consolidation of the Group’s companies are accumulated in the translation reserve. The Company’s only subsidiary is Blencowe Resources Uganda Limited, whose functional currency is USD
2.10 Earnings per share
The Company presents basic and, when appropriate, diluted earnings per share (“EPS”) data for its Ordinary Shares. Basic EPS is calculated by dividing the profit or loss attributable to ordinary shareholders of the Company by the weighted average number of Ordinary Shares outstanding during the year. Diluted EPS is calculated by adjusting the earnings and number of shares for the effects of dilutive potential Ordinary Shares.
2.11 Income tax
Income tax expense comprises current tax and deferred tax.
Current income tax
A 19% rate of corporate income tax applies to the Company. From 1 April 2023 the main corporation tax increased from 19% to 25%, and a new 19% small profits rate of corporation tax was introduced for companies whose profits do not exceed £50,000.
Deferred income tax
Deferred tax is recognised in profit or loss except to the extent that it relates to a business combination, or items recognised directly in equity or in other comprehensive income. Deferred income tax is recognised on temporary differences arising between the tax bases of assets and liabilities and their carrying amounts in the Financial Statements. Deferred income tax assets and liabilities are measured on an undiscounted basis at the tax rates that are expected to apply to the period when the related asset is realised or the liability is settled, based on tax rates (and tax laws) that have been enacted or substantively enacted at the date of the Consolidated Statement of Financial Position.
2.12 Investment in subsidiary
Investments in subsidiary are done at cost less impairment, with the investment balance being added to the exploration costs paid on behalf of the subsidiary.
2.13 Cash and cash equivalents
Cash and cash equivalents in the Company and Group statements of financial position comprise bank balances only.
3. Critical accounting estimates and judgments
In preparing the Company and Group Financial Statements, the Directors are required to make judgements, estimates and assumptions that affect the amounts reported. These estimates and judgements are continually reviewed and are based on experience and other factors, including expectations of future events that are believed to be reasonable under the circumstances.
Accounting estimates and assumptions are made concerning the future and, by their nature, may not
accurately reflect the related actual outcome. There are no key assumptions and other sources of estimation uncertainty that have a significant risk of causing a material adjustment to the carrying amounts of assets and liabilities within the next financial year.
Critical accounting estimates
Interest charge on amounts falling after one year
At year end, the NPV of the liability for surface rights to the owners of the land was £818,915 (2022: £978,255). Interest is charged on the liabilities at a rate of 5%, if the discount rate used to calculate the present value of the liabilities was to increase by 1%, the carrying value of the surface rights liability would increase by around £34,506 (2022: £60,000). The interest charged during the year was for the surface rights was £45,748 (2022: £45,916), if the rate was increased by 1% then the interest charge would increase by approximately £6,235 (2022: £5,000). For further information on the lease, please see note 15.
Critical accounting judgements
Impairment of intangible assets – exploration and evaluation costs
IFRS 6 requires entities recognising exploration and evaluation assets to perform an impairment test on those assets when specific facts and circumstances indicate an impairment test is required. The assessment involves judgement as to the status of licenses and the likelihood of renewal of exploration licenses which expire in the near future. The directors also make a judgement on the ability to meet license obligations, budgets and plans for future exploration activity, the results of that exploration activity, and to assess the recoverability of the capitalised exploration and evaluation costs on development of the project.
Going concern
In their assessment of going concern, the Directors have prepared cash flow forecast showing the Groups’ expected future expenditure. The Directors were required to make estimated and judgements over future cash flows and funding. For further information about the Group’s going concern, please see note 2.3.
4. Operating Segment activities
The Group is engaged in the business of mining. At this stage in the Group’s development, the Group is focusing on financing and continued development of the Orom-Cross Graphite Project in Uganda. This is considered to be the only operating segment.
5. Administrative fees and other expenses
|
30 Sep 2023 |
30 Sep 2022 |
|
GBP |
GBP |
Directors’ remuneration (see note 6) |
140,051 |
163,770 |
Professional fees |
226,471 |
274,333 |
Salaries (see note 7) |
150,000 |
142,500 |
Listing fees |
41,123 |
26,910 |
Audit fees |
35,000 |
29,000 |
Share option/warrant cost (see note 17) |
26,194 |
84,272 |
Administration fees |
47,000 |
47,000 |
Broker fees |
41,000 |
38,048 |
Travelling expenses |
16,852 |
34,167 |
Ugandan taxes (note 8) |
392,425 |
– |
Miscellaneous fees |
72,625 |
40,505 |
Foreign currency (gain)/loss |
110,131 |
(199,017) |
Total |
1,298,872 |
681,488 |
Key management remuneration, together with any share-based payments, are disclosed in note 7.
6. Directors’ remuneration
|
30 Sep 2023 |
30 Sep 2022 |
|
GBP |
GBP |
Base fees |
138,000 |
138,000 |
Employer NI |
2,051 |
2,770 |
Bonuses |
– |
23,000 |
Share based payments |
13,097 |
42,136 |
Total |
153,148 |
205,906 |
In addition, the Directors received options which are disclosed in note 17.
7. Key management personnel
The number of key management (excluding members the Board) employees throughout the year was as follows;
|
30 Sep 2023 |
30 Sep 2022 |
By the Company |
2 |
2 |
By the Group |
2 |
2 |
The key management employees who served during the year, together with details of their interest in the shares of the Company as at the reporting date were:
|
Number of shares |
Value of the shares |
Michael Ralston – CEO |
3,225,000 |
£188,950 |
Iain Wearing – COO |
408,333 |
£22,500 |
The total base salary costs recognised as an expense for the year was £150,000 (2022: £142,500). A further £90,000 (2022: £75,000) was capitalised as they are related to the Orom-Cross Graphite Project. Total share-based payments for the year were £13,097 (2022: £42,136). There was no other component of compensation.
8. Taxation
A 19% rate of corporate income tax applies to the Company. From 1 April 2023 the main corporation tax increased from 19% to 25%, and a new 19% small profits rate of corporation tax was introduced for companies whose profits do not exceed £50,000.
Analysis of charge in the year |
30 Sep 2023 |
30 Sep 2022 |
|
GBP |
GBP |
Current tax: |
|
|
UK Corporation tax on loss for the year |
– |
– |
Deferred tax |
– |
– |
Tax on loss on ordinary activities |
– |
– |
|
30 Sep 2023 |
30 Sep 2022 |
|
GBP |
GBP |
Loss on ordinary activities before tax |
(1,397,967) |
(1,085,474) |
Tax charge at 19% |
(265,614) |
(206,240) |
Tax effect of expenses not deductible for tax |
24,993 |
34,709 |
Tax losses for which no deferred tax asset is recognised |
240,621 |
171,531 |
Taxation charge for the year |
– |
– |
|
|
|
The Parent Company has accumulated tax losses arising in the UK of £3,002,632 (2022: £2,480,826) that are available, under current legislation, to be carried forward against future profits.
Following an inspection by the Ugandan tax authorities of the tax affairs of CARU covering the period between January 2014 and December 2022, the Group has incurred a capital gains tax charge of £392,425. This related to the acquisition by the Company of CARU in 2019. The amount was chargeable to the former owners, however this was not settled by them and under Ugandan legislation the liability is reclaimable from the acquirer if it cannot be obtained from the seller. This amount has been included within administrative expenses, as it does not relate to the profits or gains made by the Group.
9. Intangible and other assets
For the year ended 30 September 2023 intangible assets represent only capitalised costs associated with the Group’s exploration, evaluation and development of mineral resources.
Group |
Exploration assets |
Total |
GBP |
GBP |
|
Balance at 30 September 2021 |
5,296,289 |
5,296,289 |
Additions – during the year |
1,423,236 |
1,423,236 |
Impairment-Alelikongo costs |
(404,533) |
(404,533) |
Exchange differences |
300,261 |
300,261 |
Balance at 30 September 2022 |
6,615,253 |
6,615,253 |
Additions – during the year |
1,190,977 |
1,190,977 |
Exchange differences |
(201,666) |
(201,666) |
Balance at 30 September 2023 |
7,604,564 |
7,604,564 |
On 22 February 2022 the Group entered project Akelikongo which is a Nickel project with SIPA this project was to be acquired in stages. On completion of the first stage, the Board made a decision to terminate the agreement on 6 September 2022 so that they could focus on the Orom-Cross project, following the positive results from its pre-feasibility study. As a result, the costs capitalised relating to the Akelikongo project were fully impaired at that date.
Additions during the year represent exploration costs at Orom-Cross Graphite Project. Management performed a review for indications of impairment as at 30 September 2023 and concluded no impairment was required.
10. Loss per share
The calculation of the basic and diluted loss per share is based on the following data:
30 Sep 2023 |
30 Sep 2022 |
|
Earnings |
||
Loss from continuing operations for the year attributable to the equity holders of the Company (£) |
(1,397,967) |
(1,085,474) |
Number of shares |
||
Weighted average number of Ordinary Shares for the purpose of basic and diluted earnings per share |
200,041,594 |
160,790,224 |
Basic and diluted loss per share (pence) |
(0.70) |
(0.68) |
11. Investment in subsidiary
Details of the Company’s subsidiary at 30 September 2023 are as follows:
Name of the subsidiary |
Place of incorporation |
Portion of ordinary shares held |
Principal activity |
||
Consolidated African Resources Limited (Formerly Blencowe Resources Uganda Limited)
|
Uganda |
100% |
Exploration |
||
30 Sep 2023 |
30 Sep 2022 |
|
|||
Investments in subsidiary |
|
||||
Investments at the beginning of the year as previously stated |
4,892,924 |
3,936,953 |
|
||
Additions during the year |
1,135,016 |
955,971 |
|
||
Total investment in subsidiary |
6,027,940 |
4,892,924 |
|
||
12. Long term: non-current assets
|
30 Sep 2023 |
30 Sep 2022 |
||
|
Group |
Company |
Group |
Company |
|
GBP |
GBP |
GBP |
GBP |
|
|
|
|
|
Loan to subsidiaries (see below) |
– |
707,268 |
– |
549,415 |
Less: ECL provision |
– |
(35,363) |
– |
(27,471) |
Total |
– |
671,905 |
– |
521,944 |
On 18 December 2020 the Company and its subsidiary entered into a loan agreement. This agreement replaces any previous loan agreements. The facility is for an amount up to £5,000,000 and carries a base interest of 5% plus Bank of England interest rate per annum chargeable at year end. Following the acquisition of CARU, the loan is considered to be a long-term asset.
During the year, the Company agreed to cover some expenses for Consolidated African Resources Limited (CARU) for the value of £96,051 (2022: £88,148). The amount borrowed at the year end was £589,062 (2022: £487,081). The total interest charged for the year ended 30 September 2021 was £55,873 (2022: £24,351). The interest payable at the year end was £118,206 (2022: £62,334).
The value of the loan is subject to 12 months ECL of 5%, representing the possible default events over the next 12 months of the financial instrument. Due to the increase of expenses paid by the Company on behalf of CARU, the loan and its interest has increased, this has led to an increase in the provision during the year.
|
30 Sep 2023 |
30 Sep 2022 |
||
|
Group |
Company |
Group |
Company |
|
GBP |
GBP |
GBP |
GBP |
Brought forward ECL provision |
– |
27,471 |
– |
23,463 |
Provision expense |
– |
7,892 |
– |
4,008 |
Carried forward ECL provision |
– |
35,363 |
– |
27,471 |
|
|
|
|
|
13. Trade and other receivables
30 Sep 2023 |
30 Sep 2022 |
|||
|
Group |
Company |
Group |
Company |
|
GBP |
GBP |
GBP |
GBP |
Other receivables |
9,421 |
9,421 |
24,765 |
24,364 |
Amounts due from subsidiary |
– |
310,334 |
– |
229,584 |
Prepayments |
22,442 |
22,442 |
61,082 |
61,082 |
Total |
31,863 |
342,197 |
85,847 |
315,030 |
Included within other receivables is amounts receivable from CARU.
|
Group |
Company |
Group |
Company |
|
GBP |
GBP |
GBP |
GBP |
Amount receivable from CARU (formerly BRUL) |
– |
326,667 |
– |
241,667 |
Less: ECL provision |
– |
(16,333) |
– |
(12,083) |
Total |
– |
310,334 |
– |
229,584 |
In the current year the value of the receivable was subject to 12 months ECL of 5%. The increase in the provision expense is due to the charge of management fees from the Company to its subsidiary CARU. As of the year end, the amount that CARU (formerly BRUL) owes the Company on management services was £326,667 (2022: £241,667).
|
30 Sep 2023 |
30 Sep 2022 |
||
|
Group |
Company |
Group |
Company |
|
GBP |
GBP |
GBP |
GBP |
Brought forward ECL provision |
– |
12,083 |
– |
7,084 |
Provision expense |
– |
4,250 |
– |
4,999 |
Carried forward ECL provision |
– |
16,333 |
– |
12,083 |
14. Creditors: Amounts falling due within one year
|
30 Sep 2023 |
30 Sep 2022 |
||
|
Group |
Company |
Group |
Company |
|
GBP |
GBP |
GBP |
GBP |
Trade Payables |
644,585 |
528,708 |
140,018 |
127,577 |
Land Owners Liability |
– |
– |
154,403 |
– |
Ugandan taxes (note 8) |
392,425 |
– |
– |
– |
Accruals |
39,159 |
39,159 |
31,954 |
31,953 |
Total |
1,076,169 |
567,867 |
326,375 |
159,530 |
15. Creditors: Amounts falling after one year
The Ugandan Mining Act 2003 requires an applicant for a mining lease to obtain surface rights from landowners in the mineral area before the respective mining lease can be granted. Accordingly, when the Group acquired its subsidiary, it obtained surface rights by way of 49 years lease over the area. The liability to the landowners is to be paid in 10 instalments on a section basis as the project progresses. The progress on each section is not limited to any time frames and is at the Group’s discretion.
On 10 September 2022 the surface rights agreement was revised and signed between the Locomo Communal Land Association and Consolidated African Resources Limited, the surface rights remain at 49 years. The liability to the land owners will be paid in 8 instalments at defined dates with the final payment due in 2035.
30 Sep 2023 |
30 Sep 2022 |
||
GBP |
GBP |
||
Total payable as at 1 October |
978,255 |
887,560 |
|
Change in estimate |
– |
(51,316) |
|
Utilisation |
(148,468) |
– |
|
Interest charged during the period |
45,748 |
45,916 |
|
Exchange (gain)/loss |
(56,620) |
96,095 |
|
Total payable as at 30 September |
818,915 |
978,255 |
|
Analysis between current and non-current liability |
|||
Payable within 12 months |
– |
154,403 |
|
Payable after 12 months |
818,915 |
823,852 |
|
|
818,915 |
978,255 |
|
The value of the liability is measured at the present value of the contractual payments due to the Land Owners’ Association over the lease term, with the discount rate of 5%.
At the statement of financial position date, the Group undiscounted amount payable to the Land Owners is;
|
2023 |
2022 |
|
GBP |
GBP |
Payable within 1 years |
– |
154,403 |
Payable within 2-5 years |
290,388 |
308,806 |
Payable after 5 years |
871,164 |
926,418 |
|
1,161,552 |
1,389,627 |
Share capital
|
Number of shares issued |
Nominal value per share |
Share capital |
Share Premium |
Total share capital |
|
|
GBP |
GBP |
GBP |
GBP |
|
|
|
|
|
|
At 30 Sep 2021 |
121,929,950 |
|
901,316 |
5,132,081 |
6,033,397 |
|
|
|
|
|
|
Issue of Ordinary Shares |
56,000,000 |
0.005 |
280,000 |
2,520,000 |
2,800,000 |
|
|
|
|
|
|
Share issue costs |
– |
– |
– |
(171,252) |
(171,252) |
|
|
|
|
|
|
At 30 Sep 2022 |
177,929,950 |
|
1,181,316 |
7,480,829 |
8,662,145 |
|
|
|
|
|
|
Issue of Ordinary Shares
|
18,750,000 |
0.005 |
93,750 |
656,250 |
750,000 |
Issue of Ordinary Shares |
12,700,000 |
0.005 |
63,500 |
571,500 |
635,000 |
|
|
|
|
|
|
Share issue costs |
– |
– |
– |
(71,180) |
(71,180) |
|
|
|
|
|
|
At 30 Sep 2023 |
209,379,950 |
|
1,338,566 |
8,637,399 |
9,975,965 |
During the year ended 30 September 2023, the Company issued the following shares;
Date |
Number of Ordinary Shares issued |
Nominal Share Value |
Share price |
|
|
GBP |
GBP |
|
|
|
|
26 October 2022 |
18,750,000 |
0.005 |
0.0400 |
18 May 2023 |
12,700,000 |
0.005 |
0.0500 |
All of the shares issued are classed as ordinary and have similar rights attached to them. 9,375,000 warrants classified as equity were issued with the 26 October 2022 share issue, and a further 6,350,000 warrants classified as equity were issued with the 18 May 2023 share issue.
The Directors are authorised to issue 209,379,950 ordinary shares. As at 30 September 2023 the number of shares issued and fully paid were 209,344,950 (2022: 177,594,950), 35,000 shares are unpaid at 30 September 2023 (2022: unpaid shares 335,000).
16. Share based payments
Warrants
The following warrants were issued in exchange for a good or service:
|
30 Sep 2023 |
30 Sep 2022 |
||
Warrants |
Number warrants |
Weighted Average exercise price |
Number warrants |
Weighted Average exercise price |
|
|
|
|
|
Outstanding on 01 Oct |
1,250,000 |
6.00p |
1,250,000 |
6.00p |
Issued during the year |
– |
– |
– |
– |
Cancelled/ Exercised |
(1,250,000) |
– |
– |
– |
Outstanding on 30 Sep |
– |
6.00p |
1,250,000 |
6.00p |
|
|
|
|
|
Weighted average remaining contractual Life |
– |
|
0.57 years |
The warrants have no vesting period and have been recognised in full upon issue. If the warrants remain unexercised after a period of three years from the date of grant, they will expire. The holder may exercise the subscription right at any time within the subscription period.
The above warrants were valued using the Black Scholes valuation method. The assumptions used are detailed below. The expected future volatility has been determined by reference to the average volatility of similar entities:
Warrants |
|
30 Sep 2022 |
|
|
|
Weighted Average Share Price |
|
6.00p |
Weighted Average Exercise Price |
|
6.00p |
Expected Volatility |
|
56% |
Expected Life |
|
3 years |
Risk-free Rate |
|
0.23% |
Expected Dividend |
|
Nil |
Weighted Average Fair Value (GBP) |
|
32,603 |
Options
The following options were issued in exchange for a good or service:
|
30 Sep 2023 |
30 Sep 2022 |
||
Options |
Number Options |
Weighted Average exercise price |
Number Options |
Weighted Average exercise price |
|
|
|
|
|
Outstanding on 01 Oct |
16,000,000 |
6.00p |
10,000,000 |
6.00p |
Issued during the year |
5,000,000 |
5.00p |
6,000,000 |
6.00p |
Cancelled/ Exercised |
– |
– |
– |
– |
Outstanding on 30 Sept |
21,000,000 |
5.76p |
16,000,000 |
6.00p |
|
|
|
|
|
Weighted average remaining contractual Life |
|
3.23 years |
|
3.78 years |
The options issued prior to 1 October 2021 have no vesting periods and have been recognised upon issue. If the options remain unexercised after a period of five years from the date of grant, they will expire. The share options cannot be exercised if the holder has ceased employment.
The options issued in the current year and prior year include a market based vesting condition, the share options would only vest if the share price of the Company trades in excess of 10p per share for 10 consecutive days.
The above options were valued using the Black Scholes valuation method, adjusted for the probability of meeting the market-based vesting condition. The assumptions used for the options granted in the current and prior period are detailed below. The expected future volatility has been determined by reference to the average volatility of similar entities during the year:
Options |
30 Sep 2023 |
30 Sep 2022 |
|
|
|
Share Price |
4.6p |
4.3p |
Exercise Price |
5.00p |
6.00p |
Expected Volatility |
67% |
48% |
Expected Life |
5 years |
5 years |
Risk-free Rate |
3.47% |
0.76% |
Expected Dividend |
Nil |
Nil |
Fair Value (GBP) |
26,194 |
84,272 |
Deferred Tax
No deferred tax asset has been recognised in respect of share options and warrants due to the uncertainty of the future trading profits.
17. Financial instruments
17.1 Categories of financial instruments
30 Sep 2023 |
30 Sep 2022 |
|||
Group |
Company |
Group |
Company |
|
GBP |
GBP |
GBP |
GBP |
|
Financial assets at amortised cost |
||||
Trade and other receivables |
9,421 |
319,755 |
24,765 |
253,948 |
Cash and cash equivalents |
129,853 |
129,853 |
346,994 |
346,994 |
Financial liabilities at amortised cost |
||||
Trade and other payables |
1,076,169 |
567,867 |
326,375 |
159,530 |
Surface liability |
818,915 |
– |
978,255 |
– |
17.2 Financial risk management objectives and policies
The Company’s major financial instruments include cash and cash equivalents, trade and other payables and other receivables. The fair value of the Groups financial instruments are equal to their carrying value. Details of these financial instruments are disclosed in respective notes. The risks associated with these financial instruments, and the policies on how to mitigate these risks are set out below. The management manages and monitors these exposures to ensure appropriate measures are implemented in a timely and effective manner.
Currency risk
The Group operates internationally and is exposed to foreign exchange risk arising from various currency exposures, primarily with respect to the United States Dollar (“USD”) and Ugandan shilling (“UGX”). Foreign exchange risk arises from recognised monetary assets and liabilities. The Group also exposes to currency exposure, BRUL expenses are paid in both USD and UGX, with the amount payable to the land owners denominated in UGX.
The table below summaries the financial assets and liabilities denominated in foreign currencies.
|
30 Sep 2023 |
30 Sep 2022 |
||
|
USD |
UGX |
USD |
UGX |
|
|
|
|
|
Financial Assets |
891 |
– |
1,534 |
– |
|
|
|
|
|
Financial Liabilities |
41,827 |
818,915 |
35,509 |
978,256 |
With all other variables held constant, the effect on profit and loss had the functional currency of the Group weakened or strengthened against USD/UGX by 5% at the year end results in a £29,532 (2022: £28,709) change in value.
Credit risk
Credit risk arises on cash balances. The amount of credit risk is equal to the amounts stated in the statements of financial position for each of the assets (notes 12 & 13).
The Group’s policy to manage this risk is to deal with banks that are regulated entities. The Group’s principal banker, Barclays Bank PLC, is regulated by the United Kingdom Financial Services Authority, and has a credit rating of A1 (2022: A1).
Liquidity risk
Prudent liquidity risk management implies maintaining sufficient cash and marketable securities and the availability of funding through an adequate amount of committed credit. The Company aims to maintain flexibility in funding.
The maturity of the Company’s financial liabilities at the statement of financial position date, based on the contracted undiscounted payments is disclosed in notes 14, falls within one year and payable on demand.
Capital risk
The Company defines capital as the total equity of the Company. The Company’s objectives when managing capital are to safeguard the Company’s ability to continue as a going concern in order to provide returns for shareholders and benefits for other stakeholders and to maintain an optimal capital structure to reduce the cost of capital.
18. Related party transactions
Details of Directors’ remuneration are disclosed in note 6.
Sam Quinn is a director and shareholder of the Company and a Director of Lionshead Consultants Limited. During the year, Lionshead Consultants Limited charged consultancy fees of £36,000 (2022: £24,000).
19. Events after the reporting date
On 10 October 2023, the Company announced that it had received its first US$1 million mobilisation tranche payment from the Development Finance Corporation. On 25 January 2024 an additional US$1 million tranche was received from the Development Finance Corporation and the total received now is US$2 million. This represents 40% of the full US$5 million DFC grant for the Definitive Feasibility Study costs.
#POLB Poolbeg Pharma PLC – POLB 001 LPS Trial Data to be Presented at IUIS
16 November 2023 – Poolbeg Pharma (AIM: POLB, OTCQB: POLBF, ‘Poolbeg’ or the ‘Company’), a biopharmaceutical company focussed on the development and commercialisation of innovative medicines targeting diseases with a high unmet medical need, announces that an abstract highlighting the potential of POLB 001 as a groundbreaking therapy has been accepted for presentation at the 18th International Congress of Immunology (‘IUIS’), to be held 27 November – 2 December 2023 in Cape Town, South Africa.
IUIS is the world’s leading conference in the field of immunology and attracts immunologists from universities, healthcare providers, independent research organisations and industry leaders. It serves as a premier platform for the exchange of the latest cutting-edge discoveries and advancements in immunological research.
The poster presentation will discuss POLB 001’s positive LPS human challenge trial results. POLB 001 is a potential treatment of severe influenza and Cytokine Release Syndrome (CRS) associated with cancer immunotherapies. CRS is a severe inflammatory response, which may be encountered as a side effect of some therapies, manifesting a range of symptoms that can rapidly progress to a severe life-threatening reaction. An effective therapy for CRS could unlock the benefits of cancer immunotherapies, benefiting patients and healthcare systems alike.
Title: Inhibition of local and systemic inflammatory responses by POLB 001, a novel p38 MAPK inhibitor, following in vivo LPS administration in healthy volunteers
Session Date: 1 December 2023
Presentation Time: 12pm – 1pm SAST
Location: Hall 2
Presenter: Digna de Bruin, The Centre for Human Drug Research
If you would like to meet with Poolbeg Pharma, get in touch at partnering@poolbegpharma.com
Jeremy Skillington, PhD, Chief Executive Officer of Poolbeg Pharma, said: “The acceptance of this abstract at the upcoming IUIS conference underscores the potential of POLB 001 as a groundbreaking therapy. Severe influenza and Cytokine Release Syndrome associated with cancer immunotherapies are significant problems and an effective drug that can address these issues would have a significant impact on global health.”
– Ends –
Enquiries
Poolbeg Pharma Plc Jeremy Skillington, CEO Ian O’Connell, CFO
|
+44 (0) 207 183 1499 |
Cavendish Capital Markets Ltd (Nominated Adviser & Joint Broker) Geoff Nash, Charlie Beeson, Nigel Birks, Harriet Ward (ECM)
|
+44 (0) 207 220 0500 |
Singer Capital Markets (Joint Broker) Phil Davies, Sam Butcher
|
+44 (0) 207 496 3000 |
J&E Davy (Joint Broker) Anthony Farrell, Niall Gilchrist
|
+353 (0) 1 679 6363 |
Optimum Strategic Communications Nick Bastin, Hana Malik, Vici Rabbetts
|
+44 (0) 208 078 4357 |
About Poolbeg Pharma
Poolbeg Pharma plc is focussed on the development and commercialisation of innovative medicines targeting diseases with a high unmet medical need. Its model focusses upon developing its exciting clinical assets and commercialising approved and marketed drugs to fund the development of its robust pipeline of innovative products, thereby driving significant value creation.
Poolbeg is led by an experienced leadership team with a history of delivering significant shareholder value. The team and Board have been augmented with strong commercialisation expertise following the appointment of three former members of the Amryt Pharma plc leadership team, with the intention of repeating Amryt’s success and generating near term revenues.
Poolbeg’s clinical programmes target large addressable markets across cancer immunotherapies, infectious disease, and oral GLP-1 agonists for obesity and other metabolic conditions. It uses a cost-effective development philosophy to generate high quality human data to support partnering and further development. Its AI-led infectious disease programmes analyse unique data from human challenge trials to identify clinically relevant drug targets and treatments, leading to faster development and greater commercial appeal.
For more information, please go to www.poolbegpharma.com or follow us on Twitter and LinkedIn @PoolbegPharma.
#BRES Blencowe Resources PLC – DFC Grant Completed
Orom-Cross is the first pre-production graphite project to achieve support from the Development Finance Corporation (“DFC”), a USA government backed finance provider
DFC to co-fund the Definitive Feasibility Study (“DFS”) and also be lead partner for the project financing of the Orom-Cross into production
Highlights:
- Ground-breaking technical assistance agreement signed with tier one financial institution to provide Blencowe with significant funding for DFS programme.
- US$5 million to be input by the DFC as a grant, with a 20% upfront contribution (US$1 million) to be paid immediately.
- Further DFC payments will be made upon as-agreed feasibility study milestones being achieved.
- DFC is the United States of America’s (“US”) leading development finance institution that partners with the private sector to provide finance solutions for project development in markets deemed as critical to US interests.
- DFC is geared to provide funding assistance for Orom-Cross as part of the US Government’s strategic drive to secure a reliable supply chain of critical minerals and metals, within its wider US$1 trillion Biden-renewables strategy.
- As part of the US$5 million Technical Assistance Grant (“TAG”) the DFC has a right of first refusal on commercial terms to arrange project financing for the Orom-Cross project, which may deliver Blencowe with a potential full funded solution to bring Orom-Cross into production with support from the tier 1 major financial institution.
- The DFC partnership opens up the potential for Blencowe to consider a larger scale project with potentially far greater returns within the DFS. This will have material ramifications on overall Orom-Cross project value ahead.
Blencowe Resources Plc (“Blencowe” or the “Company”) (LSE: BRES) is pleased to announce it has signed a US$5 million agreement with the DFC in order to provide substantial funding for the Orom Cross DFS programme, via a Technical Assistance Grant. The DFC is a proxy for the US Government which funds the organisation and ultimately sets its vision, parameters and funding distribution.
Cameron Pearce, Executive Chairman commented;
“This funding relationship with the DFC is a unique and game-changing event for Blencowe. To the best of our knowledge there has been no other graphite project worldwide that has received a similar type grant to date from the DFC. We appreciate and we value this support and we will do everything we can to build their trust within this relationship, to ensure we deliver a high quality project together.
We believe that that having DFC as our strategic project partner substantially de-risks Orom-Cross and provides us with the means to deliver a world class project from here. Blencowe presented an excellent US$482 million NPV for Orom-Cross within the Pre-Feasibility Study last year but we are now optimistic that we can deliver an even greater value NPV within the Definitive Feasibility Study as we can expand the project horizons.
With the support of the DFC, we can address one of the major challenges and risks to any mining being the clear pathway to fund the project into production. We now have the opportunity to build the Orom-Cross project into a world class project with the comfort of a world class strategic partner.
Graphite demand is rising fast and will continue to do so. It is one of the under-rated but key components of the lithium-ion battery and it is irreplaceable in this regard. As such any future anticipated surge in demand for these batteries, not just for electric vehicles but for energy storage in all other renewable capacities, will continue to accelerate demand for graphite. We now have the means to deliver one of the leading graphite projects in the world and a highly incentivised tier one strategic partner with whom we will work with to do that.”
DFC Technical Assistance Grant (TAG)
This is an innovative funding mechanism for the DFC to become involved at an early stage with key projects that they consider to be within their direct scope and strategy. As Orom-Cross contains an estimated 2-3 billion tonnes of graphite and is one of the largest, high quality deposits worldwide it has considerable long term appeal to the DFC. Graphite remains high on the US Government critical metals and minerals list, hence this relationship with Blencowe opens a potential supply chain for high value end-product over a very long life of mine.
DFC has been working closely with Blencowe through this TAG process and both the Company and the Orom-Cross project have been subjected to all necessary due diligence in order to progress DFC interest into this monetised initial funding solution. Both parties see considerable long term value in their association with one another and Blencowe is confident this relationship will assist to provide a larger project funding solution ahead. One of the key terms within the TAG Agreement is for DFC to be mandated to provide financing for the full Orom-Cross project on commercial terms.
Prospective new graphite producers need to think outside the box to find innovative funding solutions in order to deliver their projects and the DFC relationship provides this for Orom-Cross. Not only does the US$5 million grant cover a significant portion of the DFS costs, which materially reduces the dilutionary impact to Blencowe of funding the full DFS itself, but it also provides a highly motivated full mine implementation funding partner ahead. Furthermore, the credibility associated with partnering one of the leading tier one financial institutions worldwide will open a variety of other relationships ahead as key players in the graphite market (including end user OEMs) can see a new high quality graphite project emerging that now has a more certain pathway to production.
Blencowe will immediately request the upfront payment of the initial 20% of the TAG (US$1 million), which together with the Company’s existing funds provides the means to continue DFS work underway and deliver the next as-agreed milestone payment with DFC. Once this next milestone is achieved further DFC funds are unlocked and so on, until the full grant is utilised and ultimately the DFS is completed.
One substantial advantage that now comes into play with the DFC relationship is that Blencowe is able to consider a larger-scale production strategy than it could do under the base-case scenario that the Company was considering whilst funding solo. The implications of this are enormous and the Company will provide a further update on this once the revised strategy is finalised. The expectation would be for a larger project from day one with a downstream processing facility built in-country to produce an uncoated battery-ready 99.95% SPG product. These factors above will ultimately deliver a considerably higher Net Present Value than the US$482 million NPV achieved within the 2022 Pre-Feasibility Study.
About International Development Finance Corporation
The DFC is the primary US Government finance institution set up to provide financially sound funding solutions for private-sector initiatives pertaining to critical challenges facing the world, in this case the drive towards increased sustainability across the planet. It is an agency of the United States federal government and represents US interests.
DFC’s lending capacity is used to provide loans, guarantees, equity investments and political-risk insurance for private-sector led development projects, feasibility studies and technical assistance. DFC invests across several sectors with stated goals of empowerment, innovation, investment into Africa, green energy and climate change.
Orom-Cross is directly linked with several of these goals. This project may ultimately become one of the largest graphite producing operations in the world over a very long mine life, delivering an end-product in a sustainable manner which is a non-replaceable input component to lithium-ion batteries. Demand for graphite is accelerating at a rate where it is doubling every few years, and is expected to continue growing exponentially into the future. Graphite is therefore high on the US Government critical metals and minerals list and assisting to open up long term supply chain of graphite is a key strategy.
Orom-Cross will also deliver a ‘green’ graphite product through a variety of production initiatives, including the use of hydro-electric power for all mining and processing energy requirements. Orom-Cross aims to become one of the leading sustainable mining projects worldwide and this is a very important component of the DFC charter and critical within a rapidly changing landscape where every participant along the EV supply chain will be audited on their sustainability credentials by OEMs.
Orom-Cross’s potential ability to aid in the further development of the Ugandan economy, empowering its population and driving investment and future development has also proved attractive to the DFC.
For further information please contact:
Blencowe Resources Plc Sam Quinn |
www.blencoweresourcesplc.com Tel: +44 (0)1624 681 250
|
Investor Relations
Sasha Sethi |
Tel: +44 (0) 7891 677 441
|
Tavira Financial
Jonathan Evans |
Tel: +44 (0)20 3192 1733
|
First Equity Limited
Jason Robertson |
Tel: +44(0)20 7330 1833
jasonrobertson@firstequitylimited.com
|
Twitter https://twitter.com/BlencoweRes
LinkedIn https://www.linkedin.com/company/72382491/admin/
Background
Orom-Cross Graphite Project
Orom-Cross is a potential world class graphite project both by size and end-product quality, with a high component of more valuable larger coarse flakes within the deposit.
A 21-year Mining Licence for the project was issued by the Ugandan Government in 2019 following extensive historical work on the deposit. Blencowe completed a successful Pre-Feasibility Study on the Project in July 2022 and is now within the Definitive Feasibility Study phase as it drives towards first production.
Orom-Cross presents as a large, shallow open-pitable deposit, with an initial JORC Indicated & Inferred Mineral Resource of 24.5Mt @ 6.0% TGC (Total Graphite Content). This Resource has been defined from only ~2% of the total tenement area which presents considerable upside potential ahead. Development of the resource is expected to benefit from a low strip ratio and free dig operations together with abundant inexpensive hydro-electric power off the national grid, thereby ensuring low operating costs. With all major infrastructure available at or near to site the capital costs will also be relatively low in comparison to most graphite peers.
#BRES Blencowe Resources PLC – Investor Webinar & Updated Presentation
Blencowe Resources (LSE:BRES), is pleased to announce that it will host a shareholder webinar and Q&A on Tuesday 9 May 2023 at 12:00pm UK time (19:00pm WST time).
The call will be hosted by Blencowe’s CEO, Mike Ralston who will discuss the Company’s recently announced news relating funding assistance for the further development of Blencowe’s Orom-Cross graphite project from the United States Government’s Development Finance Corporation.
Registration Details:
A recording of the webinar will also be made available on the Company’s website following the event. Investors are invited to register using the following link:
https://us02web.zoom.us/webinar/register/WN_AuIvebCoTJ-neLmgOWOaYQ
Shareholders who wish to do so are invited to submit questions via email to: info@blencoweresourcesplc.com
Latest Corporate Presentation:
An updated copy of the Company’s corporate presentation can be found on the Company’s website at:
https://blencoweresourcesplc.com/presentation/
Video Interview:
A link to a recent video interview Mike Ralston on the Proactive Investors platform is below:
Company Newsletter
Interested investors can also sign up for the Company Newsletter here:
https://blencoweresourcesplc.com/contact/
Contacts
Blencowe Resources Plc Sam Quinn (London Director) |
info@blencoweresourcesplc.com +44 (0)1624 681 250 |
Investor Enquiries Sasha Sethi
|
Tel: +44 (0) 7891 677 441 sasha@flowcomms.com
|
Tavira Financial Jonathan Evans
|
Tel: +44 (0)20 7100 5100 jonathan.evans@tavira.group |
First Equity Limited Jason Robertson |
Tel: +44 (0)20 7330 1883 jasonrobertson@firstequitylimited.com |
#POLB Poolbeg Pharma – Poolbeg to develop oral vaccine delivery platform
16 December, 2021- Poolbeg Pharma (AIM: POLB, ‘Poolbeg’ or the ‘Company’) a clinical stage infectious disease pharmaceutical company with a capital light clinical model, has signed a binding term sheet, encompassing all commercial terms, with AnaBio Technologies (AnaBio), with a full licence and collaboration agreement to follow.
The partnership allows Poolbeg exclusive access to AnaBio’s microencapsulation and nanoencapsulation technologies, IP and expertise for oral vaccine applications. Poolbeg will utilise this technology in conjunction with its own expertise in infectious diseases, vaccine development and its associated technologies to develop an oral vaccine delivery platform. Poolbeg will also investigate using its proprietary Vaccine Discovery Platform in conjunction with this jointly developed oral vaccine delivery platform.
Oral vaccines for diseases such as polio have been used successfully for decades by delivering antigens to specific areas of the gut with the objective of stimulating ‘mucosal immunity’, which prevents pathogens infecting the body. Oral vaccines offer an efficient method of administration, reducing significant challenges for distribution and administration addressing the gaps in supplying the global community as well as addressing needle-phobia.
Microencapsulation is key to delivering drugs to the gut and results in prolonged absorption profiles. Microencapsulation also helps to ensure the right dose of a product is absorbed by the body. Preliminary data has shown that AnaBio’s platform may be combined with dual nanotechnology to create a two-step delivery process with enhanced uptake to specific cells. This technology platform can be used to encapsulate a wide range of drugs including molecules such as proteins, peptides, DNA and RNA. As a result of the pandemic, mRNA vaccines have been one of the standout success stories in the fight against COVID-19.
Jeremy Skillington, PhD, CEO of Poolbeg Pharma, said: “As we have seen in the COVID-19 pandemic, the success of global vaccination drives is dependent on the effective uptake of vaccines. Oral vaccines are highly attractive due to their improved stability profiles, ease of administration, generation of mucosal immunity and being preferable to needle-phobic patients.
“The pharma sector is increasingly recognising that oral vaccines can act as standalone regimens or as boosters to injected vaccines which can struggle to generate mucosal immunity. By working with the experts at AnaBio and accessing its advanced micro and nano encapsulation technology, this places Poolbeg in a prime position to develop products for the oral vaccine market with vaccines for enteric (gut) and respiratory pathogens.”
Aidan Fitzsimons, PhD, CEO of, AnaBio Technologies, said: “The global pandemic has led to a major acceleration in vaccine development based on a deeper understanding of how to create and maintain immunity to disease; including the importance of mucosal immunity in addition to blood immunity. We believe that our patented microencapsulation technology designed to deliver intact active pharmaceutical ingredients (APIs) to specific sites within the body, combined with Poolbeg’s innate knowledge of viruses, could enable us together to create effective oral vaccines and make a significant impact on the vaccine market.”
– Ends –
Enquiries
Poolbeg Pharma Plc Jeremy Skillington, CEO Ian O’Connell, CFO
|
+353 (0) 1 644 0007 |
finnCap Ltd (Nominated Adviser & Joint Broker) Geoff Nash, James Thompson, Charlie Beeson
|
+44 (0) 20 7220 0500 |
Arden Partners PLC (Joint Broker) John Lewellyn-Lloyd, Louisa Waddell
|
+44 (0) 207 614 5900 |
J&E Davy (Joint Broker) Anthony Farrell, Niall Gilchrist
|
+353 (0) 1 679 6363 |
Instinctif Partners Melanie Toyne Sewell, Rozi Morris, Tim Field |
+44 (0) 20 7457 2020 |